| C01946 |
Oleandomycin; Amimycin; Landomycin; Matromycin; Romicil |
(P) unclassified |
| C06921 |
Clorazepate; Clorazepic acid |
(P) unclassified |
| C07051 |
Indinavir |
(P) unclassified |
| C07480 |
Theobromine; 3,7-Dimethylxanthine |
(P) unclassified |
| D00020 |
Tryptophan (USP/INN); L-Tryptophan (JP19) |
(P) unclassified |
| D00058 |
gamma-Aminobutyric acid (JAN); Gammalon (TN) |
(P) unclassified |
| D00066 |
Progesterone (JP19/USP/INN); Crinone (TN); Prometrium (TN) |
(P) Enzyme: CYP3A4 CYP2C19 / CYP inhibition: CYP3A4 CYP2C19 |
| D00105 |
Estradiol (JAN/USP/INN); Climara (TN); Divigel (TN); Estrace (TN); Estraderm (TN); Estrasorb (TN); Estring (TN); Estrogel (TN); Innofem (TN); Vagifem (TN); Vivelle (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D00107 |
Tacrolimus (USP/INN); Tacrolimus hydrate (JP19); Prograf (TN); Protopic (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D00109 |
Aspirin (JP19/USP); Aspalon (JAN); Acetylsalicylic acid; Easprin (TN); Durlaza (TN) |
(P) unclassified |
| D00118 |
Naproxen (JP19/USP/INN); Naprosyn (TN) |
(P) unclassified |
| D00120 |
Sulindac (JP19/USP/INN); Clinoril (TN) |
(P) unclassified |
| D00126 |
Ibuprofen (JP19/USP/INN); Advil (TN); Motrin (TN) |
(P) CYP inhibition: CYP2C9 |
| D00127 |
Piroxicam (JP19/USP/INN); Feldene (TN) |
(P) CYP inhibition: CYP2C9 |
| D00130 |
Diflunisal (JAN/USP/INN); Dolobid (TN) |
(P) unclassified |
| D00132 |
Ketoprofen (JP19/USP/INN); Orudis (TN) |
(P) unclassified |
| D00136 |
Haloperidol (JP19/USP/INN); Haldol (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 CYP2D6 |
| D00140 |
Erythromycin (JP19/USP/INN); Akne-mycin (TN); Eryc (TN); Erygel (TN); Pce (TN); Staticin (TN); T-stat (TN) |
(P) unclassified |
| D00141 |
Indomethacin (USP); Indometacin (JP19/INN); Aconip (TN); Indocin (TN) |
(P) unclassified |
| D00142 |
Methotrexate (JP19/USP/INN); Otrexup (TN); Xatmep (TN) |
(P) unclassified |
| D00151 |
Mefenamic acid (JP19/USP/INN); Ponstel (TN) |
(P) CYP inhibition: CYP2C9 |
| D00158 |
Tolmetin sodium (JAN/USP); Tolmetin sodium dihydrate; Tolectin (TN) |
(P) unclassified |
| D00169 |
Meclofenamate sodium (USP); Meclofenamate sodium monohydrate; Meclomen (TN) |
(P) unclassified |
| D00184 |
Cyclosporine (USP); Ciclosporin (JP19); Gengraf (TN); Neoral (TN); Restasis (TN); Sandimmune (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D00211 |
Rifampin (USP); Rifampicin (JP19/INN); Rifadin (TN); Rimactane (TN) |
(P) CYP induction: CYP3A4 |
| D00225 |
Alprazolam (JP19/USP/INN); Xanax (TN) |
(P) unclassified |
| D00227 |
Aminophylline (USP/INN); Somophyllin (TN); Theophylline ethylenediamine (TN) |
(P) Enzyme: CYP1A2 / CYP inhibition: CYP1A2 |
| D00228 |
Amoxapine (JP19/USP/INN); Asendin (TN) |
(P) CYP inhibition: CYP2D6 |
| D00235 |
Atenolol (JP19/USP/INN); Tenormin (TN) |
(P) CYP inhibition: CYP2D6 |
| D00238 |
Azathioprine (JP19/USP/INN); Azasan (TN); Imuran (TN); Jayempi (TN) |
(P) unclassified |
| D00246 |
Budesonide (JP19/USP/INN); Entocort EC (TN); Pulmicort (TN); Rhinocort (TN); Uceris (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D00252 |
Carbamazepine (JP19/USP/INN); Equetro (TN); Tegretol (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D00255 |
Carvedilol (JP19/USP/INN); Artist (TN); Coreg (TN) |
(P) Enzyme: CYP3A4 CYP1A2 / CYP inhibition: CYP1A2 CYP3A4 CYP2D6 CYP2C9 |
| D00267 |
Chlordiazepoxide (JP19/USP/INN); Libritabs (TN) |
(P) unclassified |
| D00276 |
Clarithromycin (JP19/USP/INN); Biaxin (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D00280 |
Clonazepam (JP19/USP/INN); Klonopin (TN) |
(P) unclassified |
| D00282 |
Clotrimazole (JP19/USP/INN); Lotrimin (TN); Mycelex (TN) |
(P) CYP inhibition: CYP3A4 |
| D00283 |
Clozapine (JAN/USP/INN); Clozaril (TN) |
(P) Enzyme: CYP1A2 CYP3A4 / CYP inhibition: CYP1A2 CYP3A4 |
| D00292 |
Dexamethasone (JP19/USP/INN); Decadron (TN); Maxidex (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D00293 |
Diazepam (JP19/USP/INN); Diastat (TN); Valium (TN) |
(P) Enzyme: CYP2C19 CYP3A4 / CYP inhibition: CYP3A4 CYP2C19 |
| D00295 |
Cimetidine (JP19/USP/INN); Tagamet (TN) |
(P) CYP inhibition: CYP3A4 |
| D00304 |
Divalproex sodium (USP); Valproate semisodium (INN); Depakote (TN) |
(P) unclassified |
| D00311 |
Estazolam (JP19/USP/INN); ProSom (TN) |
(P) unclassified |
| D00315 |
Etodolac (JP19/USP/INN); Lodine (TN) |
(P) unclassified |
| D00319 |
Felodipine (JP19/USP/INN); Plendil (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D00320 |
Fentanyl (JAN/USP/INN); Duragesic (TN); Subsys (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D00322 |
Fluconazole (JP19/USP/INN); Diflucan (TN) |
(P) CYP inhibition: CYP2C19 CYP3A4 |
| D00326 |
Fluoxetine (USAN/INN); Fluoxetine (TN) |
(P) CYP inhibition: CYP2C19 CYP2D6 CYP2C9 |
| D00329 |
Flurazepam (JAN/INN); Insumin (TN) |
(P) unclassified |
| D00330 |
Flurbiprofen (JP19/USP/INN); Ansaid (TN) |
(P) CYP inhibition: CYP2C9 |
| D00336 |
Glyburide (USP); Glibenclamide (JP19/INN); Diabeta (TN); Glynase (TN); Micronase (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 CYP2C9 |
| D00338 |
Halazepam (USAN/INN); Paxipam (TN) |
(P) unclassified |
| D00346 |
Isoniazid (JP19/USP/INN); Laniazid (TN) |
(P) unclassified |
| D00349 |
Isradipine (USP/INN); Dynacirc (TN) |
(P) unclassified |
| D00350 |
Itraconazole (JP19/USP); Itrizole (TN); Sporanox (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D00351 |
Ketoconazole (JP19/USP); Nizoral (TN); Xolegel (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D00354 |
Lamotrigine (JAN/USP/INN); Lamictal (TN) |
(P) unclassified |
| D00355 |
Lansoprazole (JP19/USP/INN); Prevacid (TN) |
(P) Enzyme: CYP2C19 CYP3A4 / CYP inhibition: CYP2C19 CYP3A4 |
| D00359 |
Lovastatin (USP/INN); Mevacor (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D00365 |
Lorazepam (JP19/USP/INN); Ativan (TN) |
(P) unclassified |
| D00370 |
Temazepam (USP/INN); Restoril (TN) |
(P) unclassified |
| D00371 |
Theophylline (JP19); Elixophyllin (TN); Quibron-t (TN); Theo-24 (TN); Theodur G (TN); Theolair (TN); Uniphyl (TN) |
(P) Enzyme: CYP1A2 / CYP inhibition: CYP1A2 |
| D00372 |
Thiabendazole (USP); Tiabendazole (JAN/INN); Mintezol (TN) |
(P) unclassified |
| D00375 |
Mephenytoin (USP/INN); Mesantoin (TN) |
(P) Enzyme: CYP2C19 / CYP inhibition: CYP2C19 |
| D00377 |
Mesalamine (USP); Mesalazine (JP19/INN); Apriso (TN); Asacol (TN); Canasa (TN); Delzicol (TN); Lialda (TN); Mesalamine (TN); Pentasa (TN); Rowasa (TN); Sfrowasa (TN) |
(P) unclassified |
| D00378 |
Timolol (USAN); Timolol hemihydrate; Betimol (TN) |
(P) CYP inhibition: CYP2D6 |
| D00387 |
Triazolam (JP19/USP/INN); Halcion (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D00392 |
Trimethadione (JP19/INN); Tridione (TN) |
(P) unclassified |
| D00394 |
Trimipramine (USAN/INN) |
(P) unclassified |
| D00399 |
Valproic acid (USP); Depakene (TN) |
(P) unclassified |
| D00404 |
Methsuximide (USP); Mesuximide (INN); Celontin (TN) |
(P) unclassified |
| D00415 |
Zolmitriptan (JAN/USP/INN); Zomig (TN) |
(P) Enzyme: CYP1A2 / CYP inhibition: CYP1A2 |
| D00416 |
Miconazole (JP19/USP/INN); Monistat (TN); Oravig (TN) |
(P) unclassified |
| D00420 |
Mitotane (JAN/USP/INN); Lysodren (TN) |
(P) unclassified |
| D00425 |
Nabumetone (JP19/USP/INN); Relafen (TN) |
(P) unclassified |
| D00426 |
Risperidone (JP19/USP/INN); Risperdal (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 CYP2D6 |
| D00427 |
Ritonavir (JAN/USP/INN); Norvir (TN) |
(P) CYP inhibition: CYP2D6 / CYP induction: CYP1A2 CYP2C19 |
| D00428 |
Salsalate (USP/INN); Sasapyrine (JAN); Disalcid (TN) |
(P) unclassified |
| D00429 |
Saquinavir (JAN/USP/INN); Fortovase (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D00432 |
Nadolol (JP19/USP/INN); Corgard (TN) |
(P) unclassified |
| D00434 |
Simvastatin (JP19/USP/INN); MK-733; Zocor (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D00435 |
Nevirapine (JAN/USP/INN); Viramune (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 CYP2D6 |
| D00437 |
Nifedipine (JP19/USP/INN); Adalat (TN); Afeditab CR (TN); Procardia (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D00438 |
Nimodipine (USP/INN); Nimotop (TN); Nymalize (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D00448 |
Sulfasalazine (USP/INN); Salazosulfapyridine (JP19); Azulfidine (TN) |
(P) unclassified |
| D00452 |
Suprofen (JAN/USP/INN); Profenal (TN) |
(P) CYP inhibition: CYP2C9 |
| D00455 |
Omeprazole (JP19/USP/INN); Prilosec (TN) |
(P) Enzyme: CYP2C19 / CYP inhibition: CYP2C19 |
| D00457 |
Quazepam (JAN/USP/INN); Doral (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 CYP2C9 |
| D00458 |
Quetiapine fumarate (JP19/USP); Seroquel (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D00463 |
Oxaprozin (JP19/USP/INN); Daypro (TN) |
(P) unclassified |
| D00464 |
Oxazepam (JAN/USP/INN); Serax (TN) |
(P) unclassified |
| D00470 |
Prazepam (JP19/USAN/INN); Centrax (TN) |
(P) unclassified |
| D00472 |
Prednisolone (JP19/USP/INN); Delta-cortef (TN) |
(P) unclassified |
| D00474 |
Primidone (JP19/USP/INN); Mysoline (TN) |
(P) unclassified |
| D00483 |
Propranolol hydrochloride (JP19/USP); Inderal (TN); Innopran XL (TN) |
(P) Enzyme: CYP1A2 CYP2C19 / CYP inhibition: CYP1A2 CYP2D6 CYP2C19 |
| D00484 |
Protriptyline hydrochloride (USP); Vivactil (TN) |
(P) unclassified |
| D00495 |
Paramethadione (INN); Paradione (TN) |
(P) unclassified |
| D00501 |
Pentoxifylline (JAN/USP/INN); Pentoxil (TN); Trental (TN) |
(P) unclassified |
| D00502 |
Pergolide mesylate (USP); Pergolide mesilate (JAN); Permax (TN) |
(P) unclassified |
| D00504 |
Phenacemide (JAN/INN); Phenurone (TN) |
(P) unclassified |
| D00505 |
Phenelzine sulfate (USP); Nardil (TN) |
(P) unclassified |
| D00506 |
Phenobarbital (JP19/USP/INN); Luminal (TN) |
(P) unclassified |
| D00508 |
Phensuximide (USP/INN); Milontin (TN) |
(P) unclassified |
| D00510 |
Phenylbutazone (JP19/USP/INN); Azolid (TN) |
(P) unclassified |
| D00512 |
Phenytoin (JP19/USP/INN); Dilantin (TN) |
(P) CYP inhibition: CYP2C9 |
| D00513 |
Pindolol (JP19/USP/INN); Blocklin-L (TN); Carvisken (TN); Visken (TN) |
(P) CYP inhibition: CYP2D6 |
| D00520 |
Dimenhydrinate (JP19/USP/INN); Dramamine (TN) |
(P) unclassified |
| D00528 |
Caffeine (USP); Anhydrous caffeine (JP19); Anhydrous caffeine (TN); Respia (TN) |
(P) Enzyme: CYP1A2 / CYP inhibition: CYP1A2 |
| D00531 |
Nitrazepam (JP19/USAN/INN); Benzalin (TN); Nitrazepam (TN) |
(P) unclassified |
| D00533 |
Oxcarbazepine (JAN/USP/INN); Oxtellar (TN); Trileptal (TN) |
(P) CYP inhibition: CYP2C19 |
| D00535 |
Vigabatrin (JAN/USP/INN); Sabril (TN) |
(P) unclassified |
| D00536 |
Felbamate (USPINN); Felbatol (TN) |
(P) unclassified |
| D00537 |
Topiramate (JAN/USP/INN); Topamax (TN); Trokendi xr (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D00538 |
Zonisamide (JP19/USP/INN); Excegran (TN) |
(P) unclassified |
| D00539 |
Ethosuximide (JP19/USP/INN); Zarontin (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D00542 |
Halothane (JP19/USP/INN); Fluothane (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D00550 |
Midazolam (JAN/USP/INN); Dormicum (TN); Buccolam (TN); Nayzilam (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D00553 |
Prilocaine (USP/INN); Propitocaine (JAN) |
(P) unclassified |
| D00556 |
Aminopyrine (JAN); Aminophenazone (INN) |
(P) unclassified |
| D00560 |
Pimozide (JP19/USP/INN); Orap (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D00563 |
Mirtazapine (JAN/USP/INN); Remeron (TN); Reflex (TN) |
(P) Enzyme: CYP1A2 CYP3A4 / CYP inhibition: CYP1A2 CYP3A4 CYP2D6 |
| D00564 |
Warfarin sodium (USP); Coumadin (TN); Jantoven (TN) |
(P) CYP inhibition: CYP2C9 |
| D00566 |
Sodium salicylate (JP19/USP); Salsonin (TN) |
(P) unclassified |
| D00567 |
Celecoxib (JP19/USP/INN); Celebrex (TN); Onsenal (TN) |
(P) CYP inhibition: CYP2C9 |
| D00568 |
Rofecoxib (JAN/USAN/INN); Vioxx (TN) |
(P) unclassified |
| D00570 |
Colchicine (JP19/USP) |
(CI,P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D00578 |
Voriconazole (JP19/USP/INN); Vfend (TN) |
(P) unclassified |
| D00597 |
Acebutolol hydrochloride (JP19/USP); Sectral (TN) |
(P) unclassified |
| D00598 |
Betaxolol hydrochloride (JP19/USP); Betoptic (TN); Kerlone (TN) |
(P) unclassified |
| D00599 |
Carteolol hydrochloride (JP19/USP); Cartrol (TN); Ocupress (TN) |
(P) CYP inhibition: CYP2D6 |
| D00601 |
Metoprolol tartrate (JP19/USP); Lopressor (TN) |
(P) CYP inhibition: CYP2D6 |
| D00602 |
Penbutolol sulfate (JP19/USP); Levatol (TN) |
(P) unclassified |
| D00603 |
Timolol maleate (JP19/USP); Blocadren (TN); Istalol (TN); Timoptic (TN) |
(P) CYP inhibition: CYP2D6 |
| D00606 |
Guanfacine hydrochloride (JAN/USP); Intuniv (TN); Tenex (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D00615 |
Amlodipine besylate (USP); Amlodipine besilate (JP19); Norvasc (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D00616 |
Diltiazem hydrochloride (JP19/USP); Cardizem (TN); Cartia XT (TN); Dilacor XR (TN); Dilt-CD (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D00617 |
Nicardipine hydrochloride (JP19/USAN); Cardene (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D00618 |
Nisoldipine (JAN/USAN/INN); Sular (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D00619 |
Verapamil hydrochloride (JP19/USP); Calan (TN); Covera-hs (TN); Vasolan (TN); Verelan (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D00629 |
Nitrendipine (JP19/USAN/INN); Baypress (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D00631 |
Bepridil hydrochloride (USAN); Bepridil hydrochloride hydrate (JAN); Vascor (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 CYP2D6 CYP2C9 |
| D00634 |
Bisoprolol fumarate (JP19/USP); Zebeta (TN) |
(P) unclassified |
| D00635 |
Metoprolol succinate (USP); Toprol XL (TN) |
(P) CYP inhibition: CYP2D6 |
| D00636 |
Amiodarone hydrochloride (JP19/USP); Ancaron (TN); Cordarone (TN); Nexterone (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D00644 |
Esmolol hydrochloride (JAN/USP); Brevibloc (TN) |
(P) unclassified |
| D00661 |
Cevimeline hydrochloride (USAN); Cevimeline hydrochloride hydrate (JAN); Evoxac (TN); Saligren (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 CYP2D6 |
| D00665 |
Chlorpheniramine maleate (JP19/USP); Chlor-trimeton (TN); Teldrin (TN) |
(P) unclassified |
| D00670 |
Donepezil hydrochloride (JP19/USP); Aricept (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D00679 |
Ergotamine tartrate (JP19/USP); Ergomar (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D00680 |
Methylergonovine maleate (USP); Methylergometrine maleate (JP19); Methergine (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D00681 |
Methysergide maleate (USP); Sansert (TN) |
(P) unclassified |
| D00687 |
Salmeterol xinafoate (JAN/USP); Serevent (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D00691 |
Dyphylline (USP); Diprophylline (JAN/INN); Lufyllin (TN) |
(P) unclassified |
| D00693 |
Chlordiazepoxide hydrochloride (JAN/USP); Librium (TN) |
(P) unclassified |
| D00694 |
Clorazepate dipotassium (JP19/USP); Tranxene (TN) |
(P) unclassified |
| D00695 |
Flurazepam hydrochloride (USP); Flurazepam dihydrochloride; Dalmane (TN) |
(P) unclassified |
| D00696 |
Midazolam hydrochloride (USAN); Versed (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D00700 |
Mephobarbital (JAN/USP); Methylphenobarbital (INN); Mebaral (TN) |
(P) Enzyme: CYP2C19 / CYP inhibition: CYP2C19 |
| D00701 |
Phenobarbital sodium (JAN/USP/INN); Luminal sodium (TN) |
(P) unclassified |
| D00708 |
Ethotoin (JAN/USP/INN); Accenon (TN); Peganone (TN) |
(P) unclassified |
| D00709 |
Levetiracetam (JP19/USP/INN); Keppra (TN); E keppra (TN) |
(P) unclassified |
| D00710 |
Valproate sodium (USAN); Sodium valproate (JP19); Depakene (TN); Selenica (TN) |
(P) unclassified |
| D00722 |
Oxybutynin chloride (USP); Oxybutynin hydrochloride (JP19); Ditropan (TN); Gelnique (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D00724 |
Rabeprazole sodium (JP19/USP); Aciphex (TN); Pariet (TN) |
(P) Enzyme: CYP2C19 CYP3A4 / CYP inhibition: CYP3A4 CYP2C19 |
| D00727 |
Olsalazine sodium (USAN); Dipentum (TN) |
(P) unclassified |
| D00742 |
Etanercept (USAN/INN); Etanercept (genetical recombination) (JAN); Etanercept (genetical recombination) [Etanercept biosimilar 1] (JAN); Etanercept (genetical recombination) [Etanercept biosimilar 2] (JAN); Enbrel (TN) |
(P) unclassified |
| D00746 |
Interferon beta-1b (USAN/INN); Interferon beta-1b (genetical recombination) (JAN); Betaseron (TN); Extavia (TN) |
(P) unclassified |
| D00749 |
Leflunomide (JAN/USP/INN); Arava (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D00752 |
Mycophenolate mofetil (JAN/USP); Cellcept (TN) |
(P) unclassified |
| D00753 |
Sirolimus (JAN/USAN/INN); Rapamune (TN); Rapamycin (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D00754 |
Thalidomide (JAN/USP/INN); Thalomid (TN); Thaled (TN) |
(P) unclassified |
| D00765 |
Rocuronium bromide (JAN/USP/INN); Zemuron (TN) |
(P) unclassified |
| D00769 |
Clopidogrel bisulfate (USP); Clopidogrel sulfate (JP19); Clopidogrel sulfate tablets (JP19); Clopidogrel hydrogen sulphate; Isocover (TN); Plavix (TN) |
(P) Enzyme: CYP2C19 CYP1A2 / CYP inhibition: CYP1A2 CYP2C19 |
| D00775 |
Riluzole (JAN/USP/INN); Rilutek (TN) |
(P) Enzyme: CYP1A2 / CYP inhibition: CYP1A2 |
| D00780 |
Bromocriptine mesylate (USP); Bromocriptine mesilate (JP19); Parlodel (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D00784 |
Ropinirole hydrochloride (JAN/USP); Requip (TN) |
(P) Enzyme: CYP1A2 / CYP inhibition: CYP1A2 |
| D00789 |
Chlorpromazine hydrochloride (JP19/USP); Sonazine (TN) |
(P) CYP inhibition: CYP2D6 |
| D00809 |
Amitriptyline hydrochloride (JP19/USP); Elavil (TN) |
(P) Enzyme: CYP3A4 CYP2C19 / CYP inhibition: CYP3A4 CYP2D6 CYP2C19 |
| D00810 |
Choline salicylate (JAN/USAN/INN); Arthropan (TN) |
(P) unclassified |
| D00811 |
Clomipramine hydrochloride (JP19/USP); Anafranil (TN) |
(P) Enzyme: CYP3A4 CYP2C19 / CYP inhibition: CYP3A4 CYP2D6 CYP2C19 |
| D00812 |
Desipramine hydrochloride (JAN/USP); Norpramin (TN) |
(P) unclassified |
| D00813 |
Ketorolac tromethamine (USP); Acular (TN); Toradol (TN) |
(P) unclassified |
| D00814 |
Doxepin hydrochloride (USP); Sinequan (TN); Zonalon (TN) |
(P) Enzyme: CYP2C19 / CYP inhibition: CYP2D6 CYP2C19 CYP2C9 |
| D00815 |
Imipramine hydrochloride (JP19/USP); Tofranil (TN) |
(P) Enzyme: CYP3A4 CYP2C19 / CYP inhibition: CYP3A4 CYP2D6 CYP2C19 |
| D00816 |
Nortriptyline hydrochloride (JP19/USP/INN); Pamelor (TN) |
(P) CYP inhibition: CYP2D6 |
| D00817 |
Bupropion hydrochloride (JAN/USP); Wellbutrin (TN); Zyban (TN) |
(P) unclassified |
| D00818 |
Maprotiline hydrochloride (JP19/USP); Ludiomil (TN) |
(P) CYP inhibition: CYP2D6 |
| D00819 |
Nefazodone hydrochloride (USP); Serzone (TN) |
(P) unclassified |
| D00820 |
Trazodone hydrochloride (JAN/USP); Desyrel (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 CYP2D6 |
| D00821 |
Venlafaxine hydrochloride (JAN/USP); Effexor (TN) |
(P) CYP inhibition: CYP2D6 |
| D00822 |
Citalopram hydrobromide (USP); Celexa (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP2C19 CYP3A4 CYP2D6 |
| D00823 |
Fluoxetine hydrochloride (JAN/USP); Prozac (TN); Sarafem (TN) |
(P) CYP inhibition: CYP2C19 CYP2D6 CYP2C9 |
| D00824 |
Fluvoxamine maleate (JP19/USP); Luvox (TN) |
(P) CYP inhibition: CYP1A2 CYP2C19 CYP3A4 CYP2D6 |
| D00825 |
Sertraline hydrochloride (JAN/USP); Zoloft (TN) |
(P) Enzyme: CYP2C19 CYP3A4 / CYP inhibition: CYP3A4 CYP2C19 CYP2C9 |
| D00826 |
Tranylcypromine sulfate (USP); Parnate (TN) |
(P) unclassified |
| D00827 |
Magnesium salicylate (USP); Magnesium salicylate tetrahydrate; Magan (TN) |
(P) unclassified |
| D00831 |
Mefloquine hydrochloride (JP19/USP); Lariam (TN) |
(P) unclassified |
| D00836 |
Buprenorphine hydrochloride (JP19/USP); Buprenex (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D00848 |
Dextromethorphan hydrobromide (USP); Dextromethorphan hydrobromide hydrate (JP19); Benylin DM (TN) |
(P) CYP inhibition: CYP2D6 |
| D00851 |
Erythromycin estolate (USP); Erythromycin estorate (JAN); Ilosone (TN) |
(P) unclassified |
| D00880 |
Butoconazole nitrate (USP); Femstat (TN); Gynazole-1 (TN) |
(P) unclassified |
| D00881 |
Econazole nitrate (JAN/USP); Ecoza (TN); Spectazole (TN) |
(P) unclassified |
| D00882 |
Miconazole nitrate (JP19/USP); Micatin (TN); Monistat (TN) |
(P) unclassified |
| D00885 |
Oxiconazole nitrate (JAN/USAN); Oxistat (TN) |
(P) unclassified |
| D00886 |
Sulconazole nitrate (JAN/USP); Exelderm (TN) |
(P) unclassified |
| D00887 |
Atorvastatin calcium anhydorous; Lipitor (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D00888 |
Terconazole (USP/INN); Terazol 3 (TN) |
(P) unclassified |
| D00889 |
Cerivastatin sodium (JAN/USAN); Baycol (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D00890 |
Tioconazole (JAN/USP/INN); Vagistat-1 (TN) |
(P) unclassified |
| D00892 |
Fluvastatin sodium (JAN/USP); Lescol (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 CYP2C9 |
| D00893 |
Pravastatin sodium (JP19/USP); CS-514; Pravachol (TN) |
(P) unclassified |
| D00894 |
Amprenavir (JAN/USAN/INN); Agenerase (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D00897 |
Indinavir sulfate (USP); Crixivan (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D00899 |
Nelfinavir mesylate (USAN/INN); Nelfinavir mesilate (JAN); Viracept (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D00903 |
Diclofenac potassium (USP); Cambia (TN); Cataflam (TN); Zipsor (TN) |
(P) CYP inhibition: CYP2C9 |
| D00904 |
Diclofenac sodium (JP19/USP); Solaraze (TN); Voltaren (TN) |
(P) CYP inhibition: CYP2C9 |
| D00950 |
Levonorgestrel (JAN/USP/INN); Mirena (TN); Norplant (TN); Skyla (TN) |
(P) unclassified |
| D00961 |
Bicalutamide (JP19/USP/INN); Casodex (TN) |
(P) CYP inhibition: CYP3A4 |
| D00964 |
Letrozole (JAN/USP/INN); Femara (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D00968 |
Fenoprofen calcium (JAN/USP); Nalfon (TN) |
(P) unclassified |
| D00969 |
Meloxicam (JAN/USP/INN); Mobic (TN) |
(P) CYP inhibition: CYP2C9 |
| D00970 |
Naproxen sodium (USP); Anaprox (TN) |
(P) unclassified |
| D00971 |
Sodium thiosalicylate; Thiosalicylic acid sodium salt; Rexolate (TN) |
(P) unclassified |
| D00987 |
Cabergoline (JP19/USP/INN); Cabaser (TN); Dostinex (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D01025 |
Levobunolol hydrochloride (JAN/USP); Betagan (TN) |
(P) unclassified |
| D01026 |
Sotalol hydrochloride (JAN/USP); Betapace (TN); Sorine (TN) |
(P) unclassified |
| D01037 |
1,4-Dimethyl-7-isopropylazulene (JAN); Guaiazulene; Azunol (TN) |
(P) unclassified |
| D01049 |
Nimesulide (JAN/INN) |
(P) unclassified |
| D01061 |
Irinotecan hydrochloride (USP); Irinotecan hydrochloride hydrate (JP19); Irinotecan hydrochloride trihydrate; CPT 11; CPT-11; Campto (TN); Camptosar (TN); Onivyde (TN) |
(P) unclassified |
| D01078 |
Telithromycin (JAN/USAN/INN); Ketek (TN) |
(P) CYP inhibition: CYP2D6 |
| D01087 |
Methyl salicylate (JP19/NF) |
(P) unclassified |
| D01092 |
Lanoconazole (JP19/INN); Latoconazole; Astat (TN) |
(P) unclassified |
| D01104 |
Barnidipine hydrochloride (JAN); Hypoca (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D01107 |
Milnacipran hydrochloride (JAN/USAN); Savella (TN); Toledomin (TN) |
(P) unclassified |
| D01110 |
Melitracen hydrochloride (JAN/USAN) |
(P) unclassified |
| D01115 |
Eplerenone (JP19/USAN/INN); Inspra (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D01122 |
Ibuprofen piconol (JP19/USAN); Staderm (TN) |
(P) CYP inhibition: CYP2C9 |
| D01145 |
Azelnidipine (JP19/INN); Calblock (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D01160 |
Saquinavir mesylate (USP); Saquinavir mesilate (JAN); Invirase (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D01163 |
Ergonovine maleate (USP); Ergometrine maleate (JP19); Ergometrine (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D01164 |
Aripiprazole (JP19/USP/INN); Abilify (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 CYP2D6 |
| D01172 |
Diphenylpyraline hydrochloride (JAN); Hispril (TN); Vena (TN) |
(P) unclassified |
| D01173 |
Cilnidipine (JP19/INN); Atelec (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D01176 |
Blonanserin (JP19/INN); AD 5423 |
(CI,P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D01179 |
Duloxetine hydrochloride (JAN/USP); Cymbalta (TN); Yentreve (TN) |
(P) Enzyme: CYP1A2 / CYP inhibition: CYP1A2 |
| D01182 |
Alprenolol hydrochloride (JP19/USAN); Regletin (TN) |
(P) CYP inhibition: CYP2D6 |
| D01183 |
Tolfenamic acid (JAN/INN); Clotam (TN) |
(P) unclassified |
| D01185 |
Protizinic acid (JAN/INN) |
(P) unclassified |
| D01189 |
Metiazinic acid (JAN/INN) |
(P) unclassified |
| D01190 |
Ethylphenacemide (JAN); Pheneturide (INN) |
(P) unclassified |
| D01207 |
Omeprazole sodium (USAN); Losec sodium (TN) |
(P) Enzyme: CYP2C19 / CYP inhibition: CYP2C19 |
| D01213 |
Tolvaptan (JP19/USAN/INN); Samsca (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D01230 |
Flunitrazepam (JP19/USAN/INN); Rohypnol (TN) |
(P) unclassified |
| D01235 |
Josamycin (JP19/USAN/INN); Leucomycin A3; JM |
(P) CYP inhibition: CYP3A4 |
| D01239 |
Prednisolone sodium succinate (JP19/USP); Kohakusanin (TN) |
(P) unclassified |
| D01243 |
Prilocaine hydrochloride (USP); Propitocaine hydrochloride (JAN); Citanest (TN) |
(P) unclassified |
| D01245 |
Bromazepam (JP19/USAN/INN); Lectopam (TN) |
(P) unclassified |
| D01252 |
Alclofenac (JAN/USP/INN); Mervan (TN) |
(P) unclassified |
| D01253 |
Clobazam (JAN/USAN/INN); Mystan (TN); Onfi (TN) |
(P) Enzyme: CYP3A4 CYP2C19 / CYP inhibition: CYP3A4 CYP2C19 |
| D01254 |
Tofisopam (JP19/INN); Emandaxin (TN) |
(P) unclassified |
| D01267 |
Floctafenine (JAN/USAN/INN); Idarac (TN) |
(P) unclassified |
| D01268 |
Cloxazolam (JP19/INN); Sepazon (TN) |
(P) unclassified |
| D01271 |
Bufexamac (JAN/INN); Anderm (TN) |
(P) unclassified |
| D01276 |
Atazanavir sulfate (JAN/USAN); Reyataz (TN) |
(P) CYP inhibition: CYP3A4 |
| D01278 |
Oxazolam (JP19/INN); Serenal (TN) |
(P) unclassified |
| D01279 |
Flutoprazepam (JAN/INN); Restas (TN) |
(P) unclassified |
| D01280 |
Warfarin potassium (JP19); Athrombin-K (TN) |
(P) CYP inhibition: CYP2C9 |
| D01285 |
Lofepramine hydrochloride (JAN/USAN); Amplit (TN) |
(P) unclassified |
| D01286 |
Flutazolam (JAN/INN); Coreminal (TN) |
(P) unclassified |
| D01287 |
Levobupivacaine hydrochloride (JAN/USAN); Chirocaine (TN) |
(P) Enzyme: CYP3A4 CYP1A2 / CYP inhibition: CYP1A2 CYP3A4 |
| D01289 |
Suxibuzone (JAN/INN) |
(P) unclassified |
| D01290 |
Nicergoline (JP19/USAN/INN); Sermion (TN) |
(P) unclassified |
| D01292 |
Medazepam (JP19/INN); Pamnace (TN) |
(P) unclassified |
| D01293 |
Ethyl loflazepate (JP19/INN); Meilax (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D01296 |
Methylphenidate hydrochloride (JAN/USP); Concerta (TN); Metadate (TN); Quillivant xr (TN); Ritalin (TN) |
(P) unclassified |
| D01303 |
Flunarizine hydrochloride (JAN/USAN) |
(P) CYP inhibition: CYP2D6 |
| D01305 |
Feprazone (JAN/INN) |
(P) unclassified |
| D01314 |
Dibenzepin hydrochloride (JAN/USAN) |
(P) unclassified |
| D01316 |
Mexazolam (JAN/INN); Melex (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D01322 |
Troleandomycin (USAN/INN); Triacetyloleandomycin (JAN); TAO; Tao (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D01325 |
Tiaprofenic acid (JAN/INN); Surgam (TN) |
(P) unclassified |
| D01328 |
Clotiazepam (JP19/INN); Rize (TN) |
(P) unclassified |
| D01330 |
Clidanac (JAN/INN) |
(P) unclassified |
| D01339 |
Midecamycin (JP19/INN); Medemycin (TN) |
(P) CYP inhibition: CYP3A4 |
| D01341 |
Tiaramide hydrochloride (JP19/USAN); Solantal (TN) |
(P) unclassified |
| D01344 |
Fenbufen (JP19/USAN/INN) |
(P) unclassified |
| D01348 |
Terguride (JAN/INN); Teluron (TN) |
(P) unclassified |
| D01353 |
Emorfazone (JP19/INN); Pentoil (TN) |
(P) unclassified |
| D01354 |
Fludiazepam (JP19/INN); Erispan (TN) |
(P) unclassified |
| D01355 |
Tramadol hydrochloride (JP19/USP); Ultram (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 CYP2D6 |
| D01358 |
Mianserin hydrochloride (JAN/USAN); Tetramide (TN) |
(P) Enzyme: CYP3A4 CYP1A2 / CYP inhibition: CYP1A2 CYP3A4 CYP2D6 |
| D01361 |
Erythromycin ethylsuccinate (JP19/USP); E.E.S. (TN); Eryped (TN); Erythrocin W (TN) |
(P) unclassified |
| D01370 |
Cladribine (JAN/USP/INN); Leustatin (TN); Mavenclad (TN) |
(P) unclassified |
| D01372 |
Zopiclone (JP19/INN); Amoban (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D01380 |
Isopropylantipyrine (JP19); Propyphenazone (INN); Yoshipyrin (TN) |
(P) unclassified |
| D01382 |
Metharbital (JAN/INN); Gemonil (TN) |
(P) unclassified |
| D01394 |
Epirizole (JP19/USAN); Mebron (TN) |
(P) unclassified |
| D01397 |
Ampiroxicam (JP19/INN); Flucam (TN) |
(P) CYP inhibition: CYP2C9 |
| D01399 |
Fentanyl citrate (JP19/USP); Abstral (TN); Fentora (TN); Lazanda (TN); Oralet (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D01408 |
Flurazepam hydrochloride (JP19); Flurazepam monohydrochloride; Dalmate (TN) |
(P) unclassified |
| D01410 |
Benzydamine hydrochloride (JAN/USAN); Tantum (TN) |
(P) unclassified |
| D01418 |
Tamibarotene (JAN/USAN/INN); Am 80; Amnoid (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D01425 |
Lopinavir (JAN/USP/INN) |
(P) unclassified |
| D01429 |
Fosfluconazole (JAN/INN); Prodif (TN) |
(P) CYP inhibition: CYP2C19 CYP3A4 |
| D01437 |
Nifenazone (JAN/INN) |
(P) unclassified |
| D01453 |
Caffeine hydrate (JP19); Caffeine monohydrate |
(P) Enzyme: CYP1A2 / CYP inhibition: CYP1A2 |
| D01454 |
Bupranolol hydrochloride (JP19) |
(P) unclassified |
| D01462 |
Lisuride maleate (JAN) |
(P) unclassified |
| D01466 |
Ethenzamide (JP19/INN) |
(P) unclassified |
| D01471 |
Esatenolol (JAN/INN); (S)-Atenolol |
(P) unclassified |
| D01475 |
Flurbiprofen axetil (JAN); FP 83; Ropion (TN) |
(P) CYP inhibition: CYP2C9 |
| D01477 |
Opipramol hydrochloride (JAN/USAN); Insidon (TN) |
(P) unclassified |
| D01480 |
Isoconazole nitrate (JAN); Adestan-G (TN) |
(P) unclassified |
| D01492 |
Bucumolol hydrochloride (JP19) |
(P) unclassified |
| D01504 |
Bufetolol hydrochloride (JP19); Adobiol (TN) |
(P) unclassified |
| D01512 |
Befunolol hydrochloride (JAN); Bentos (TN) |
(P) unclassified |
| D01513 |
Alminoprofen (JP19/INN); Minalfen (TN) |
(P) unclassified |
| D01514 |
Etizolam (JP19/INN); Sedekopan (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 CYP2C9 |
| D01545 |
Aceclofenac (JAN/INN) |
(P) unclassified |
| D01546 |
Dothiepin hydrochloride (USAN); Dosulepin hydrochloride (JAN); Prothiaden (TN) |
(P) CYP inhibition: CYP2D6 |
| D01547 |
Zaltoprofen (JP19/INN); CN 100; Peon (TN) |
(P) unclassified |
| D01553 |
Manidipine hydrochloride (JP19); Manidipine dihydrochloride; Calslot (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D01557 |
Glycol salicylate (JAN); Ethylene glycol salicylate; Norgesic (TN); Phlogont (TN) |
(P) unclassified |
| D01562 |
Aranidipine (JAN/INN); Sapresta (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D01564 |
Rilmazafone hydrochloride hydrate (JP19); Rilmazafone hydrochloride dihydrate; Rilmazafone hydrochloride; Rhythmy (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D01565 |
Indometacin farnesil (JAN); Infree (TN) |
(P) unclassified |
| D01566 |
Gusperimus trihydrochloride (USAN); Gusperimus hydrochloride (JAN); Spanidin (TN) |
(P) unclassified |
| D01567 |
Ketophenylbutazone (JAN); Kebuzone (INN) |
(P) unclassified |
| D01578 |
Pranoprofen (JP19/INN); Elicapric (TN) |
(P) unclassified |
| D01581 |
Flufenamic acid (JAN/USAN/INN); Arlef (TN) |
(P) unclassified |
| D01582 |
Acemetacin (JP19/INN); Rantudil (TN) |
(P) unclassified |
| D01583 |
Pirfenidone (JAN/USAN/INN); Esbriet (TN) |
(P) Enzyme: CYP1A2 CYP2C19 / CYP inhibition: CYP1A2 CYP2D6 CYP2C19 |
| D01593 |
Nimetazepam (JAN/INN); Erimin (TN) |
(P) unclassified |
| D01594 |
Bendazac (JAN/USAN/INN); Iwazac (TN) |
(P) unclassified |
| D01604 |
Efonidipine hydrochloride ethanolate (JAN); Efonidipine hydrochloride ethanol; Efonidipine hydrochloride; NZ 105 ethanolate; Landel (TN) |
(P) unclassified |
| D01614 |
Acetylkitasamycin (JP19); Neo-leucomycin H (TN) |
(P) unclassified |
| D01620 |
Neticonazole hydrochloride (JAN); Atolant (TN) |
(P) unclassified |
| D01627 |
Diphenylpyraline teoclate (JAN); Piprinhydrinate; Plokon (TN) |
(P) unclassified |
| D01630 |
Propentofylline (JAN/INN) |
(P) unclassified |
| D01636 |
Midecamycin acetate (JP19); Miocamycin; Miocamycin (TN) |
(P) CYP inhibition: CYP3A4 |
| D01656 |
Brovincamine fumarate (JAN); Sabromin (TN) |
(P) unclassified |
| D01657 |
Lormetazepam (JAN/USAN/INN); Loramet (TN) |
(P) unclassified |
| D01661 |
Bucolome (JAN/INN); Paramidin (TN) |
(P) unclassified |
| D01664 |
Omoconazole nitrate (JAN/USAN) |
(P) unclassified |
| D01675 |
Felbinac (JP19/USAN/INN); Dolinac (TN) |
(P) unclassified |
| D01703 |
Ciclesonide (JAN/USAN/INN); Alvesco (TN); Omnaris (TN); Zetonna (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D01706 |
Migrenin (JP19) |
(P) unclassified |
| D01708 |
Fluticasone propionate (JAN/USP); Cutivate (TN); Flonase (TN); Flovent (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D01709 |
Loxoprofen sodium hydrate (JP19); Lorfenamin (TN); Loxonin (TN) |
(P) unclassified |
| D01710 |
Roxithromycin (JP19/USAN/INN); Rulide (TN) |
(P) unclassified |
| D01712 |
Theophylline sodium acetate (JAN) |
(P) Enzyme: CYP1A2 / CYP inhibition: CYP1A2 |
| D01718 |
Mofezolac (JAN/INN) |
(P) CYP inhibition: CYP2C9 |
| D01741 |
Celiprolol hydrochloride (JAN/USAN); Selectol (TN) |
(P) unclassified |
| D01744 |
Brotizolam (JP19/USAN/INN); Lendormin (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D01745 |
Domperidone (JP19/USAN/INN); Motilium (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D01758 |
Haloxazolam (JP19/INN); Somelin (TN) |
(P) unclassified |
| D01762 |
Dipyrone (USAN); Sulpyrine hydrate (JP19); Metamizole sodium salt monohydrate |
(P) unclassified |
| D01765 |
Proglumetacin maleate (JAN); Miridacin (TN) |
(P) unclassified |
| D01767 |
Tenoxicam (JAN/USAN/INN); Tilcotil (TN) |
(P) CYP inhibition: CYP2C9 |
| D01771 |
Proxyphylline (JAN/INN); Monophyllin (TN) |
(P) unclassified |
| D01775 |
Bifonazole (JP19/USAN/INN); Mycospor (TN) |
(P) unclassified |
| D01776 |
Antipyrine (JP19/USP); Phenazone (INN) |
(P) unclassified |
| D01787 |
Sulthiame (USAN); Sultiame (JP19); Ospolot (TN) |
(P) unclassified |
| D01788 |
Amfenac sodium (USAN); Amfenac sodium hydrate (JAN); Fenazox (TN) |
(P) unclassified |
| D01793 |
Bifemelane hydrochloride (JAN) |
(P) unclassified |
| D01794 |
Bopindolol malonate (JAN); Sandonorm (TN) |
(P) CYP inhibition: CYP2D6 |
| D01795 |
Tilisolol hydrochloride (JAN); Selecal (TN) |
(P) unclassified |
| D01806 |
Oxprenolol hydrochloride (JP19/USP); Okuspurecol (TN) |
(P) unclassified |
| D01811 |
Salicylamide (JAN/USP/INN) |
(P) unclassified |
| D01823 |
Ufenamate (JAN/INN); Flufenamic acid butyl ester; Combec (TN) |
(P) unclassified |
| D01832 |
Modafinil (JAN/USP/INN); Provigil (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP2C19 CYP3A4 / CYP induction: CYP1A2 CYP3A4 |
| D01841 |
Felbinac ethyl (JAN); LM 001 |
(P) unclassified |
| D01847 |
Landiolol hydrochloride (JAN/USAN); ONO 1101 hydrochloride; Onoact (TN); Rapiblyk (TN) |
(P) unclassified |
| D01849 |
Lercanidipine hydrochloride (JAN/USAN); Cardiovasc (TN) |
(P) unclassified |
| D01851 |
Mepranoprofen arbamel (JAN); Y-23023 |
(P) unclassified |
| D01862 |
Pitavastatin calcium (JAN); NK 104; Livalo (TN) |
(P) CYP inhibition: CYP2C9 |
| D01865 |
Pelubiprofen (JAN/INN) |
(P) unclassified |
| D01866 |
Lornoxicam (JP19/USAN/INN); Lorcam (TN) |
(P) CYP inhibition: CYP2C9 |
| D01874 |
Vedaprofen (JAN/USAN/INN) |
(P) unclassified |
| D01896 |
Cilostazol (JP19/USP/INN); Pletal (TN) |
(P) Enzyme: CYP3A4 CYP2C19 / CYP inhibition: CYP3A4 CYP2C19 |
| D01897 |
Rokitamycin (JAN/INN); Ricamycin (TN) |
(P) unclassified |
| D01898 |
Haloperidol decanoate (JAN/USP); Halomonth (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 CYP2D6 |
| D01908 |
Nilvadipine (JP19/USAN/INN); Nivadil (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D01915 |
Rosuvastatin calcium (JP19/USP); ZD 4522; Crestor (TN) |
(P) unclassified |
| D01920 |
Tenatoprazole (JAN/INN); TU 199 |
(P) unclassified |
| D01933 |
Vatanidipine hydrochloride (JAN); AE 0047; Calbren (TN) |
(P) unclassified |
| D01958 |
Indenolol hydrochloride (JP19) |
(P) unclassified |
| D01963 |
Ibufenac (JAN/USAN/INN); Dytransin (TN) |
(P) unclassified |
| D01969 |
Gallopamil hydrochloride (JAN) |
(P) unclassified |
| D01973 |
Eletriptan hydrobromide (JAN/USAN); Relpax (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D01974 |
Tilmacoxib (JAN/USAN/INN) |
(P) unclassified |
| D01975 |
Fentiazac (JAN/USAN/INN) |
(P) unclassified |
| D01977 |
Gefitinib (JP19/USAN/INN); Iressa (TN) |
(P) unclassified |
| D01980 |
Luliconazole (JAN/USAN/INN); Lulicon (TN); Luzu (TN) |
(P) CYP inhibition: CYP2C19 CYP3A4 |
| D01984 |
Esomeprazole magnesium (USP); Esomeprazole magnesium hydrate (JP19); Esomeprazole magnesium trihydrate; Nexium (TN) |
(P) Enzyme: CYP2C19 / CYP inhibition: CYP2C19 |
| D02000 |
Kitasamycin tartrate (JP19); Leucomycin tartrate (TN) |
(P) unclassified |
| D02008 |
Tadalafil (JAN/USP/INN); Adcirca (TN); Cialis (TN); Zalutia (TN) |
(CI,P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D02009 |
Erythromycin lactobionate (JP19/USP); Erythrocin (TN) |
(P) unclassified |
| D02017 |
Oxtriphylline (USP); Choline theophyllinate (INN); Choline theophylline (JAN); Theophyline and choline; Theocolin (TN) |
(P) Enzyme: CYP1A2 / CYP inhibition: CYP1A2 |
| D02045 |
Benidipine hydrochloride (JP19); KW 3049; Coniel (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D02075 |
Sodium gualenate (INN); Sodium guaiazulenesulfonate; Azunol ST (TN) |
(P) unclassified |
| D02081 |
Metipranolol hydrochloride; Optipranolol (TN) |
(P) unclassified |
| D02096 |
Fosphenytoin sodium (USP); Cerebyx (TN); Sesquient (TN) |
(P) CYP inhibition: CYP2C9 / CYP induction: CYP3A4 |
| D02097 |
Tiagabine hydrochloride (USP); Gabitril (TN) |
(P) unclassified |
| D02101 |
Codeine phosphate (USP); Codeine phosphate hydrate (JP19) |
(P) CYP inhibition: CYP2D6 |
| D02103 |
Phenytoin sodium (USP); Phenytoin sodium for injection (JP19); Aleviatin (TN); Dilantin (TN) |
(P) CYP inhibition: CYP2C9 |
| D02110 |
Indomethacin sodium (USP); Indometacin sodium hydrate (JAN); Indomethacin sodium trihydrate; Indometacin sodium; Indocin I.V. (TN) |
(P) unclassified |
| D02114 |
Hydroxychloroquine sulfate (JAN/USP); Plaquenil (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D02115 |
Methotrexate sodium; Trexall (TN); Rasuvo (TN) |
(P) unclassified |
| D02134 |
Azithromycin hydrate (JP19); Azithromycin dihydrate; Zithromac (TN); Zmax (TN); Azimycin (TN) |
(P) unclassified |
| D02169 |
Croconazole hydrochloride (JP19); Pilzcin (TN) |
(P) unclassified |
| D02184 |
Erythromycin stearate (JP19/USP); Bristamycin (TN) |
(P) unclassified |
| D02186 |
Oleandomycin phosphate (JAN); Matromycin (TN) |
(P) unclassified |
| D02211 |
Dihydroergotamine mesylate (USP); Dihydroergotamine mesilate (JP19); Migranal (TN); Trudhesa (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D02229 |
Sildenafil citrate (JAN/USP); Revatio (TN); Viagra (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D02258 |
Atorvastatin calcium (USP); Atorvastatin calcium hydrate (JP19); Atorvastatin calcium trihydrate; Atorvaliq (TN); Lipitor (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D02260 |
Paroxetine hydrochloride hemihydrate (USP); Paroxetine hydrochloride hydrate (JP19); Paxil (TN) |
(P) CYP inhibition: CYP2D6 |
| D02264 |
Dipotassium glycyrrhizinate (JAN); Glycyrrhizinate dipotassium; Neubormitin (TN) |
(P) unclassified |
| D02268 |
Ergoloid mesylates (USP); Dihydroergotoxine mesilate (JP19); Circanol (TN); Hydergine (TN); Inorter (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D02269 |
Kitasamycin (JP19/USAN); Leucomycin (TN) |
(P) unclassified |
| D02272 |
Quinidine sulfate (USP); Quinidine sulfate hydrate (JP19); Quinidex (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D02290 |
Flurbiprofen sodium (USP); Ocufen (TN) |
(P) CYP inhibition: CYP2C9 |
| D02338 |
Acebutolol (USAN/INN) |
(P) unclassified |
| D02341 |
Meclofenamic acid (USAN/INN) |
(P) unclassified |
| D02342 |
Bisoprolol (JAN/USAN/INN) |
(P) unclassified |
| D02350 |
Fenoprofen (USAN/INN) |
(P) unclassified |
| D02355 |
Tolmetin (USAN/INN) |
(P) unclassified |
| D02356 |
Verapamil (USAN/INN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D02357 |
Methysergide (USAN/INN) |
(P) unclassified |
| D02358 |
Metoprolol (USAN/INN) |
(P) CYP inhibition: CYP2D6 |
| D02360 |
Sertraline (INN) |
(P) Enzyme: CYP2C19 CYP3A4 / CYP inhibition: CYP3A4 CYP2C19 CYP2C9 |
| D02362 |
Paroxetine (USP/INN) |
(P) CYP inhibition: CYP2D6 |
| D02372 |
Perospirone hydrochloride hydrate (JP19); Lullan (TN) |
(P) unclassified |
| D02374 |
Metipranolol (USAN/INN) |
(P) unclassified |
| D02389 |
Primidolol (USAN/INN) |
(P) unclassified |
| D02408 |
Trimipramine maleate (JAN/USP); Surmontil (TN) |
(P) unclassified |
| D02420 |
Acetylspiramycin (JP19); Spiramycin II |
(P) unclassified |
| D02484 |
Artemether and lumefantrine; Coartem (TN) |
(P) unclassified |
| D02490 |
Tylosin (USP/INN); TS; Tylan (TN) |
(P) unclassified |
| D02492 |
Tilmicosin (USP/INN); TMS; Micotil (TN) |
(P) unclassified |
| D02493 |
Tilmicosin phosphate (USAN); TP |
(P) unclassified |
| D02497 |
Fosamprenavir (INN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D02498 |
Lopinavir and ritonavir; Kaletra (TN) |
(P) unclassified |
| D02523 |
Erythromycin acistrate (USAN); Erasis (TN) |
(P) unclassified |
| D02524 |
Erythromycin gluceptate (USP); Erythromycin glucoheptonate; Ilotycin gluceptate (TN) |
(P) unclassified |
| D02525 |
Erythromycin propionate (USAN) |
(P) unclassified |
| D02537 |
Dronedarone (INN) |
(P) unclassified |
| D02555 |
Posaconazole (JAN/USAN/INN); Noxafil (TN) |
(P) CYP inhibition: CYP3A4 |
| D02556 |
Ravuconazole (prop.INN) |
(P) unclassified |
| D02557 |
Chlormidazole (INN) |
(P) unclassified |
| D02559 |
Toloxatone (INN); Humoryl (TN) |
(P) unclassified |
| D02561 |
Moclobemide (USAN/INN); Aurorix (TN) |
(P) Enzyme: CYP2C19 / CYP inhibition: CYP2C19 |
| D02562 |
Rasagiline mesylate (USAN); Rasagiline mesilate (JAN); Azilect (TN) |
(P) Enzyme: CYP1A2 / CYP inhibition: CYP1A2 |
| D02565 |
Dimetacrine (INN) |
(P) unclassified |
| D02566 |
Maprotiline (USAN) |
(P) CYP inhibition: CYP2D6 |
| D02567 |
Escitalopram oxalate (JAN/USP); Lexapro (TN) |
(P) Enzyme: CYP3A4 CYP2C19 / CYP inhibition: CYP3A4 CYP2D6 CYP2C19 |
| D02570 |
Desvenlafaxine succinate (USAN); Desvenlafaxine succinate hydrate (JAN); Desvenlafaxine succinate monohydrate; Pristiq (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D02572 |
Viloxazine hydrochloride (USAN); Qelbree (TN); Vivalan (TN) |
(P) CYP inhibition: CYP2D6 |
| D02573 |
Reboxetine mesylate (USAN); Reboxetine mesilate; Vestra (TN) |
(P) unclassified |
| D02574 |
Atomoxetine hydrochloride (JAN/USP); Tomoxetine hydrochloride; Strattera (TN) |
(P) CYP inhibition: CYP2D6 |
| D02575 |
Tianeptine (INN); Stablon (TN) |
(P) unclassified |
| D02578 |
Agomelatine (INN); Valdoxan (TN) |
(P) unclassified |
| D02579 |
Iproniazid (INN) |
(P) unclassified |
| D02580 |
Isocarboxazid (INN); Marplan (TN) |
(P) unclassified |
| D02582 |
Fenticonazole (INN) |
(P) unclassified |
| D02583 |
Fenticonazole nitrate (USAN); Lomexin (TN) |
(P) unclassified |
| D02584 |
Aliconazole (INN) |
(P) unclassified |
| D02585 |
Vibunazole; Bay N-7133 |
(P) unclassified |
| D02586 |
Alteconazole (INN) |
(P) unclassified |
| D02593 |
Pantoprazole sodium (USP); Pantoprazole sodium hydrate (JAN); Protonix (TN) |
(P) Enzyme: CYP2C19 / CYP inhibition: CYP2C19 |
| D02596 |
Tocilizumab (USAN/INN); Tocilizumab (genetical recombination) (JAN); Tocilizumab (genetical recombination) [Tocilizumab biosimilar 1] (JAN); Tocilizumab (genetical recombination) [Tocilizumab biosimilar 2] (JAN); Tocilizumab-aazg; Tocilizumab-bavi; Tocilizumab-anoh; Actemra (TN); Avtozma (TN); Tofidence (TN); Tyenne (TN) |
(P) unclassified |
| D02597 |
Adalimumab (USAN/INN); Adalimumab (genetical recombination) (JAN); Adalimumab (genetical recombination) [Adalimumab biosimilar 1] (JAN); Adalimumab (genetical recombination) [Adalimumab biosimilar 2] (JAN); Adalimumab (genetical recombination) [Adalimumab biosimilar 3] (JAN); Adalimumab (genetical recombination) [Adalimumab biosimilar 4] (JAN); Adalimumab-adaz; Adalimumab-adbm; Adalimumab-afzb; Adalimumab-atto; Adalimumab-bwwd; Adalimumab-fkjp; Adalimumab-aaty; Adalimumab-aacf; Adalimumab-aqvh; Adalimumab-ryvk; Humira (TN); Abrilada (TN); Amjevita (TN); Cyltezo (TN); Hadlima (TN); Hyrimoz (TN) |
(P) unclassified |
| D02598 |
Infliximab (USAN/INN); Infliximab (genetical recombination) (JAN); Infliximab (genetical recombination) [Infliximab biosimilar 1] (JAN); Infliximab (genetical recombination) [Infliximab biosimilar 2] (JAN); Infliximab (genetical recombination) [Infliximab biosimilar 3] (JAN); Infliximab-dyyb; Infliximab-abda; Infliximab-axxq; Remicade (TN); Inflectra (TN); Renflexis (TN); Avsola (TN); Zymfentra (TN) |
(P) unclassified |
| D02600 |
Demoxepam (USAN/INN) |
(P) unclassified |
| D02624 |
Eszopiclone (JAN/USP/INN); Estorra (TN); Lunesta (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D02629 |
Fluspirilene (USAN/INN); Imap (TN) |
(P) unclassified |
| D02630 |
Penfluridol (USAN/INN); Semap (TN) |
(P) unclassified |
| D02633 |
Lomerizine hydrochloride (JAN); Terranas (TN) |
(P) unclassified |
| D02689 |
Ramelteon (JAN/USAN/INN); Rozerem (TN) |
(P) Enzyme: CYP1A2 / CYP inhibition: CYP1A2 |
| D02691 |
Somatropin (USP/INN); Somatropin (genetical recombination) (JAN); Human growth hormone (JAN); Asellacrin (TN); Humatrope (TN); Nutropin (TN); Omnitrope (TN) |
(P) CYP inhibition: CYP2C19 |
| D02706 |
Sodium gualenate hydrate (JAN); Azulene sulfonate sodium hydrate; Sodium guaiazulene sulfonate; Azunol (TN) |
(P) unclassified |
| D02709 |
Valdecoxib (USAN/INN); Bextra (TN) |
(P) unclassified |
| D02714 |
Everolimus (JAN/USAN/INN); Afinitor (TN); Votubia (TN); Zortress (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D02715 |
Balsalazide disodium (USP); Colazide (TN) |
(P) unclassified |
| D02732 |
Pranlukast hydrate (JP19); Onon (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D02765 |
Adaprolol maleate (USAN) |
(P) unclassified |
| D02766 |
Valpromide (INN); Depamide (TN) |
(P) unclassified |
| D02770 |
Adinazolam (USAN/INN) |
(P) unclassified |
| D02771 |
Adinazolam mesylate (USAN) |
(P) unclassified |
| D02787 |
Alaproclate (USAN/INN) |
(P) unclassified |
| D02800 |
Alefacept (USAN/INN); Amevive (TN) |
(P) unclassified |
| D02802 |
Alemtuzumab (USAN/INN); Alemtuzumab (genetical recombination) (JAN); Campath (TN); Lemtrada (TN) |
(P) unclassified |
| D02834 |
Alprenoxime hydrochloride (USAN) |
(P) unclassified |
| D02861 |
Indinavir sulfate ethanolate (JAN); Crixivan (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D02867 |
Fosamprenavir calcium hydrate (JAN); Lexiva (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D02884 |
Ambuphylline (USAN); Bufylline (BAN); Butaphyllamine (TN) |
(P) unclassified |
| D02893 |
Amesergide (USAN/INN) |
(P) unclassified |
| D02914 |
Amlodipine maleate (USAN); Amvaz (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D02934 |
Anakinra (USAN/INN); Anakinra (genetical recombination) (JAN); Kineret (TN) |
(P) unclassified |
| D02944 |
Anirolac (USAN/INN) |
(P) unclassified |
| D02968 |
Aprepitant (JAN/USP/INN); Aponvie (TN); Emend (TN); Cinvanti (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D02985 |
Arofylline (USAN/INN) |
(P) unclassified |
| D02995 |
Asenapine maleate (JAN/USAN); Saphris (TN) |
(P) Enzyme: CYP1A2 / CYP inhibition: CYP1A2 |
| D03023 |
Azaconazole (USAN/INN) |
(P) unclassified |
| D03033 |
Azathioprine sodium (USP); Imuran (TN) |
(P) unclassified |
| D03051 |
Bamifylline hydrochloride (USAN) |
(P) unclassified |
| D03058 |
Basiliximab (USAN/INN); Basiliximab (genetical recombination) (JAN); Simulect (TN) |
(P) unclassified |
| D03067 |
Belfosdil (USAN/INN) |
(P) unclassified |
| D03068 |
Belimumab (USAN); Belimumab (genetical recombination) (JAN); Benlysta (TN); LymphoStat-B (TN) |
(P) unclassified |
| D03080 |
Benoxaprofen (USAN/INN); Oraflex (TN) |
(P) unclassified |
| D03083 |
Bentazepam (USAN/INN) |
(P) unclassified |
| D03098 |
Berythromycin (USAN/INN); Erythromycin B |
(P) unclassified |
| D03106 |
Bexarotene (JAN/USAN/INN); Targretin (TN) |
(P) unclassified |
| D03150 |
Bortezomib (JAN/USAN/INN); Velcade (TN) |
(P) unclassified |
| D03163 |
Bromfenac sodium (USAN); Bromfenac sodium hydrate (JP19); Bromfenac sodium sesquihydrate; Bromday (TN); Prolensa (TN); Xibrom (TN); Yellox (TN) |
(P) unclassified |
| D03164 |
Bromindione (USAN/INN) |
(P) unclassified |
| D03165 |
Bromocriptine (USAN/INN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D03170 |
Bucindolol hydrochloride (USAN) |
(P) unclassified |
| D03177 |
Bunolol hydrochloride (USAN) |
(P) unclassified |
| D03198 |
Butoxamine hydrochloride (USAN) |
(P) unclassified |
| D03199 |
Butriptyline hydrochloride (USAN) |
(P) unclassified |
| D03203 |
Abatacept (USAN/INN); Abatacept (genetical recombination) (JAN); Orencia (TN) |
(P) unclassified |
| D03204 |
Abetimus sodium (USAN) |
(P) unclassified |
| D03218 |
Axitinib (JAN/USAN); Inlyta (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D03222 |
Belatacept (USAN/INN); Nulojix (TN) |
(P) unclassified |
| D03253 |
Brecanavir (USAN) |
(P) unclassified |
| D03254 |
Flufenamate aluminum (JAN); Flufenamic acid aluminum; Opyrin (TN) |
(P) unclassified |
| D03260 |
Vardenafil hydrochloride hydrate (JAN); Vardenafil monohydrochloride trihydrate; Levitra (TN); Staxyn (TN) |
(CI,P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D03385 |
Carbaspirin calcium (USAN); Carbasalate calcium (INN) |
(P) unclassified |
| D03410 |
Carprofen (USP/INN); Rimadyl (TN) |
(P) unclassified |
| D03415 |
Carvedilol phosphate (USAN); Carvedilol phosphate hydrate (JAN); Coreg CR (TN) |
(P) Enzyme: CYP3A4 CYP1A2 / CYP inhibition: CYP1A2 CYP3A4 CYP2D6 CYP2C9 |
| D03441 |
Certolizumab pegol (USAN/INN); Certolizumab pegol (genetical recombination) (JAN); Cimzia (TN) |
(P) unclassified |
| D03449 |
Cetamolol hydrochloride (USAN) |
(P) unclassified |
| D03489 |
Cicloprofen (USAN/INN) |
(P) unclassified |
| D03490 |
Cicloprolol hydrochloride (USAN) |
(P) unclassified |
| D03516 |
Cipamfylline (USAN/INN) |
(P) unclassified |
| D03526 |
Cisconazole (USAN/INN) |
(P) unclassified |
| D03536 |
Clentiazem maleate (JAN/USAN) |
(P) unclassified |
| D03540 |
Cliprofen (USAN/INN) |
(P) unclassified |
| D03560 |
Clopirac (USAN/INN) |
(P) unclassified |
| D03562 |
Clorazepate monopotassium (USAN) |
(P) unclassified |
| D03601 |
Crilvastatin (USAN/INN) |
(P) unclassified |
| D03631 |
Cyprazepam (USAN/INN) |
(P) unclassified |
| D03639 |
Daclizumab (USAN/INN); Zenapax (TN); Zinbryta (TN) |
(P) unclassified |
| D03643 |
Dalvastatin (USAN/INN) |
(P) unclassified |
| D03652 |
Darbufelone mesylate (USAN) |
(P) unclassified |
| D03655 |
Darodipine (USAN/INN) |
(P) unclassified |
| D03656 |
Darunavir (USAN/INN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D03658 |
Dasatinib (JAN/INN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D03669 |
Deferasirox (JAN/USAN/INN); Exjade (TN); Jadenu (TN) |
(P) CYP inhibition: CYP1A2 / CYP induction: CYP3A4 |
| D03689 |
Deracoxib (USAN) |
(P) unclassified |
| D03710 |
Etoricoxib (USAN/INN) |
(P) unclassified |
| D03712 |
Firocoxib (USAN/INN); Equioxx (TN) [veterinary] |
(P) unclassified |
| D03714 |
Lumiracoxib (USAN/INN) |
(P) unclassified |
| D03715 |
Dexibuprofen (USAN/INN) |
(P) unclassified |
| D03716 |
Parecoxib (USAN/INN) |
(P) unclassified |
| D03717 |
Parecoxib sodium (USAN); Dynastat (TN) |
(P) unclassified |
| D03718 |
Dexibuprofen lysine (USAN); Dexibuprofen lysine monohydrate; Doctrin (TN) |
(P) unclassified |
| D03727 |
Dexpemedolac (USAN/INN) |
(P) unclassified |
| D03729 |
Dexpropranolol hydrochloride (USAN) |
(P) unclassified |
| D03737 |
Dextofisopam (USAN/INN) |
(P) unclassified |
| D03759 |
Diacetolol hydrochloride (USAN) |
(P) unclassified |
| D03798 |
Dicumarol (USAN); Dicoumarol (INN) |
(P) unclassified |
| D03799 |
Dienogest (JAN/USAN/INN); Endometrion (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D03816 |
Tenivastatin calcium (USAN) |
(P) unclassified |
| D03820 |
Dutasteride (JAN/USP/INN); Avodart (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D03830 |
Diltiazem malate (USAN); Tiamate (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D03833 |
Indinavir (USAN); Indinavir hydrate |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D03835 |
Fosamprenavir calcium (USAN); Lexiva (TN); Telzir (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D03837 |
Fosamprenavir sodium (USAN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D03839 |
Droxinavir hydrochloride (USAN) |
(P) unclassified |
| D03840 |
Palinavir (USAN/INN) |
(P) unclassified |
| D03842 |
Telinavir (USAN/INN) |
(P) unclassified |
| D03843 |
Tipranavir disodium (USAN) |
(P) unclassified |
| D03844 |
Phenytoin, phenobarbital and caffeine and sodium benzoate; Hydantol F (TN) |
(P) Enzyme: CYP2C19 / CYP inhibition: CYP2C19 CYP2C9 |
| D03846 |
Dimethyl fumarate (JAN/USAN); Tecfidera (TN) |
(P) unclassified |
| D03865 |
Dirithromycin (USP/INN); Dynabac (TN) |
(P) unclassified |
| D03883 |
Doconazole (USAN/INN) |
(P) unclassified |
| D03898 |
Doxofylline (USAN/INN); Maxivent (TN) |
(P) unclassified |
| D03914 |
Dronedarone hydrochloride (USP); Multaq (TN) |
(P) unclassified |
| D03936 |
Econazole (USAN/INN) |
(P) unclassified |
| D03940 |
Eculizumab (USAN/INN); Eculizumab (genetical recombination) (JAN); Eculizumab-aagh; Eculizumab-aeeb; Soliris (TN); Bkemv (TN); Epysqli (TN) |
(P) unclassified |
| D03959 |
Efalizumab (USAN/INN); Raptiva (TN) |
(P) unclassified |
| D03997 |
Enilconazole (USAN/INN) |
(P) unclassified |
| D04003 |
Enolicam sodium (USAN); Enolicam sodium monohydrate |
(P) unclassified |
| D04006 |
Enprofylline (USAN/INN) |
(P) unclassified |
| D04023 |
Erlotinib hydrochloride (JAN/USAN); Tarceva (TN) |
(P) Enzyme: CYP3A4 CYP1A2 / CYP inhibition: CYP1A2 CYP3A4 |
| D04024 |
Lapatinib ditosylate (USAN); Lapatinib tosilate hydrate (JAN); Lapatinib ditosylate monohydrate; Tykerb (TN); Tyverb (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D04048 |
Ropivacaine hydrochloride (USP); Ropivacaine hydrochloride hydrate (JAN); Anapeine (TN) |
(P) Enzyme: CYP1A2 CYP3A4 / CYP inhibition: CYP1A2 CYP3A4 |
| D04054 |
Erythromycin salnacedin (USAN); Erythromycin salnacedin dihydrate |
(P) unclassified |
| D04056 |
Esomeprazole sodium (USAN); Nexium IV (TN) |
(P) Enzyme: CYP2C19 / CYP inhibition: CYP2C19 |
| D04102 |
Etofenamate (USAN/INN) |
(P) unclassified |
| D04105 |
Etoperidone hydrochloride (USAN); Etonin (TN) |
(P) unclassified |
| D04142 |
Fenclofenac (USAN/INN) |
(P) unclassified |
| D04144 |
Fenclorac (USAN/INN) |
(P) unclassified |
| D04145 |
Fendosal (USAN/INN); Alnovin (TN) |
(P) unclassified |
| D04147 |
Fenethylline hydrochloride (USAN) |
(P) unclassified |
| D04148 |
Fenfluramine hydrochloride (JAN/USAN); Fintepla (TN); Pondimin (TN) |
(P) Enzyme: CYP1A2 CYP2C19 CYP3A4 / CYP inhibition: CYP1A2 CYP3A4 CYP2D6 CYP2C19 |
| D04187 |
Fingolimod hydrochloride (JAN/USAN); Gilenya (TN) |
(P) unclassified |
| D04190 |
Flestolol sulfate (USAN) |
(P) unclassified |
| D04193 |
Flordipine (USAN/INN) |
(P) unclassified |
| D04206 |
Flufenisal (USAN/INN) |
(P) unclassified |
| D04248 |
Fosazepam (USAN/INN) |
(P) unclassified |
| D04260 |
Fostedil (USAN/INN) |
(P) unclassified |
| D04273 |
Furaprofen (USAN/INN) |
(P) unclassified |
| D04277 |
Furobufen (USAN/INN) |
(P) unclassified |
| D04300 |
Ganaxolone (USAN/INN); Ztalmy (TN) |
(P) Enzyme: CYP3A4 CYP2C19 / CYP inhibition: CYP3A4 CYP2D6 CYP2C19 |
| D04314 |
Gepirone hydrochloride (USAN); Exxua (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D04340 |
Dextromethorphan hydrobromide and potassium cresolsulfonate; Medicon (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 CYP2D6 |
| D04358 |
Golimumab (USAN/INN); Golimumab (genetical recombination) (JAN); Golimumab (genetical recombination) [Golimumab biosimilar 1] (JAN); Simponi (TN) |
(P) unclassified |
| D04483 |
Ethinylestradiol and norethisterone; Norethindrone and ethinyl estradiol; Synphase T28 (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D04490 |
Ibuprofen aluminum (USAN) |
(P) CYP inhibition: CYP2C9 |
| D04530 |
Indoprofen (USAN/INN) |
(P) unclassified |
| D04554 |
Interferon beta-1a (USAN); Interferon beta-1a (genetical recombination) (JAN); Avonex (TN); Rebif (TN) |
(P) unclassified |
| D04605 |
Iprindole (USAN/INN) |
(P) unclassified |
| D04624 |
Isoconazole (USAN/INN) |
(P) unclassified |
| D04638 |
Isoxepac (USAN/INN); Artil (TN) |
(P) unclassified |
| D04639 |
Isoxicam (USAN/INN); Maxicam (TN) |
(P) unclassified |
| D04641 |
Istradefylline (JAN/USAN/INN); Nourianz (TN); Nouriast (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D04650 |
Ketazolam (USAN/INN) |
(P) unclassified |
| D04657 |
Lacidipine (USAN/INN); Motens (TN) |
(P) unclassified |
| D04666 |
Lanreotide acetate (JAN/USAN); Somatuline (TN) |
(P) unclassified |
| D04687 |
Lenalidomide (JAN/USAN/INN); Revlimid (TN) |
(P) unclassified |
| D04693 |
Lergotrile (USAN/INN) |
(P) unclassified |
| D04694 |
Lergotrile mesylate (USAN) |
(P) unclassified |
| D04710 |
Levobetaxolol hydrochloride (USAN); Betaxon (TN) |
(P) unclassified |
| D04721 |
Levotofisopam (USAN/INN) |
(P) unclassified |
| D04725 |
Lexithromycin (USAN/INN) |
(P) unclassified |
| D04733 |
Lidoflazine (USAN/INN); Angex (TN) |
(P) unclassified |
| D04748 |
Lisofylline (USAN/INN); ProTec (TN) |
(P) unclassified |
| D04768 |
Lonafarnib (JAN/USAN/INN); Zokinvy (TN) |
(CI,P) CYP inhibition: CYP2C19 |
| D04820 |
Lurasidone hydrochloride (JAN/USAN); SM 13496; Latuda (TN) |
(CI,P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D04863 |
Mavacoxib (USAN) |
(P) unclassified |
| D04882 |
Medazepam hydrochloride (USAN); Nobrium (TN) |
(P) unclassified |
| D04888 |
Medroxalol (USAN/INN) |
(P) unclassified |
| D04889 |
Medroxalol hydrochloride (USAN) |
(P) unclassified |
| D04896 |
Megalomicin potassium phosphate (USAN) |
(P) unclassified |
| D05011 |
Metoprolol fumarate (USP); Lopressor (TN) |
(P) CYP inhibition: CYP2D6 |
| D05024 |
Mibefradil dihydrochloride (USAN); Posicor (TN) |
(P) CYP inhibition: CYP1A2 |
| D05028 |
Midazolam maleate (USAN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D05039 |
Minaprine (USAN/INN); Cantor (TN) |
(P) CYP inhibition: CYP2D6 |
| D05040 |
Minaprine hydrochloride (USAN) |
(P) CYP inhibition: CYP2D6 |
| D05092 |
Muromonab-CD3 (JAN/USAN/INN); Orthoclone okt3 (TN) |
(P) unclassified |
| D05094 |
Mycophenolate mofetil hydrochloride (USAN); Cellcept (TN) |
(P) unclassified |
| D05095 |
Mycophenolate sodium (USP); Myfortic (TN) |
(P) unclassified |
| D05096 |
Mycophenolic acid (USAN/INN) |
(P) unclassified |
| D05121 |
Naproxol (USAN/INN) |
(P) unclassified |
| D05125 |
Naxifylline (USAN/INN) |
(P) unclassified |
| D05127 |
Nebivolol (USAN/INN) |
(P) CYP inhibition: CYP2D6 |
| D05143 |
Nepafenac (JAN/USAN/INN); Nevanac (TN) |
(P) unclassified |
| D05153 |
Neutramycin (USAN) |
(P) unclassified |
| D05181 |
Aspirin aluminum (JP19) |
(P) unclassified |
| D05200 |
Nomifensine maleate (USAN); Merital (TN) |
(P) unclassified |
| D05218 |
Ocrelizumab (USAN); Ocrelizumab (genetical recombination) (JAN); Ocrevus (TN) |
(P) unclassified |
| D05259 |
Omeprazole magnesium (USP); Prilosec OTC (TN) |
(P) Enzyme: CYP2C19 / CYP inhibition: CYP2C19 |
| D05261 |
Omeprazole sodium injection (JAN); Omeprazole sodium hydrate; Omepral (TN) |
(P) Enzyme: CYP2C19 / CYP inhibition: CYP2C19 |
| D05268 |
Orconazole nitrate (USAN) |
(P) unclassified |
| D05319 |
Oxyphenbutazone hydrate; Tandearil (TN) |
(P) unclassified |
| D05345 |
Pamatolol sulfate (USAN) |
(P) unclassified |
| D05351 |
Josamycin propionate (JP19); Josamy (TN) |
(P) CYP inhibition: CYP3A4 |
| D05353 |
Pantoprazole (USAN/INN) |
(P) Enzyme: CYP2C19 / CYP inhibition: CYP2C19 |
| D05367 |
Parconazole hydrochloride (USAN) |
(P) unclassified |
| D05374 |
Paroxetine hydrochloride (USP); Paxil (TN) |
(P) CYP inhibition: CYP2D6 |
| D05375 |
Paroxetine mesylate (USAN); Brisdelle (TN); Pexeva (TN) |
(P) CYP inhibition: CYP2D6 |
| D05380 |
Pazopanib hydrochloride (JAN/USAN); Votrient (TN) |
(P) unclassified |
| D05404 |
Pemedolac (USAN/INN) |
(P) unclassified |
| D05429 |
Aminophylline hydrate (JP19) |
(P) Enzyme: CYP1A2 / CYP inhibition: CYP1A2 |
| D05442 |
Perhexiline maleate (USAN) |
(P) CYP inhibition: CYP2D6 |
| D05451 |
Phenbutazone sodium glycerate (USAN) |
(P) unclassified |
| D05457 |
Phenprocoumon (USAN/INN); Liquamar (TN) |
(P) unclassified |
| D05462 |
Oxycodone hydrochloride hydrate (JP19) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D05511 |
Piroxicam betadex (USAN) |
(P) CYP inhibition: CYP2C9 |
| D05512 |
Piroxicam cinnamate (USAN) |
(P) CYP inhibition: CYP2C9 |
| D05513 |
Piroxicam olamine (USAN) |
(P) CYP inhibition: CYP2C9 |
| D05515 |
Pirprofen (USAN/INN) |
(P) unclassified |
| D05538 |
Mozenavir (INN) |
(P) unclassified |
| D05587 |
Practolol (USAN) |
(P) unclassified |
| D05598 |
Pravadoline maleate (USAN) |
(P) unclassified |
| D05619 |
Prodolic acid (USAN/INN) |
(P) unclassified |
| D05621 |
Progabide (USAN/INN); Gabren (TN) |
(P) unclassified |
| D05710 |
Reclazepam (USAN/INN) |
(P) unclassified |
| D05713 |
Relomycin (USAN/INN) |
(P) unclassified |
| D05717 |
Repromicin (USAN/INN) |
(P) unclassified |
| D05722 |
Revaprazan hydrochloride (USAN) |
(P) unclassified |
| D05757 |
Rosaramicin (USAN/INN) |
(P) unclassified |
| D05758 |
Rosaramicin butyrate (USAN) |
(P) unclassified |
| D05759 |
Rosaramicin propionate (USAN) |
(P) unclassified |
| D05760 |
Rosaramicin sodium phosphate (USAN) |
(P) unclassified |
| D05761 |
Rosaramicin stearate (USAN) |
(P) unclassified |
| D05775 |
Rufinamide (JAN/USP/INN); Banzel (TN) |
(P) unclassified |
| D05788 |
Salcolex (USAN); Salcolex tetrahydrate |
(P) unclassified |
| D05789 |
Salethamide maleate (USAN) |
(P) unclassified |
| D05791 |
Salicylate meglumine (USAN) |
(P) unclassified |
| D05793 |
Salnacedin (USAN/INN) |
(P) unclassified |
| D05800 |
Saperconazole (USAN/INN) |
(P) unclassified |
| D05811 |
Sedecamycin (USAN/INN) |
(P) unclassified |
| D05829 |
Sergolexole maleate (USAN) |
(P) unclassified |
| D05830 |
Sermetacin (USAN/INN) |
(P) unclassified |
| D05900 |
Timoprazole (INN) |
(P) unclassified |
| D05901 |
Picoprazole (INN) |
(P) unclassified |
| D05906 |
Leminoprazole (INN) |
(P) unclassified |
| D05908 |
Spiramycin (JAN/USAN/INN); Rovamycin (TN) |
(P) unclassified |
| D05928 |
Stiripentol (JAN/USAN/INN); Diacomit (TN) |
(P) Enzyme: CYP1A2 CYP2C19 CYP3A4 / CYP inhibition: CYP1A2 CYP3A4 CYP2C19 |
| D05937 |
Sudoxicam (USAN/INN) |
(P) unclassified |
| D05942 |
Sulazepam (USAN/INN) |
(P) unclassified |
| D05995 |
Talmetacin (USAN/INN) |
(P) unclassified |
| D05998 |
Talosalate (USAN/INN) |
(P) unclassified |
| D06012 |
Tazifylline hydrochloride (USAN) |
(P) unclassified |
| D06060 |
Teludipine hydrochloride (USAN) |
(P) unclassified |
| D06068 |
Temsirolimus (JAN/USAN/INN); Torisel (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D06082 |
Tesicam (USAN) |
(P) unclassified |
| D06103 |
Theophylline (USP); Theophylline monohydrate; Accurbron (TN) |
(P) Enzyme: CYP1A2 / CYP inhibition: CYP1A2 |
| D06104 |
Theophylline sodium glycinate (USP); Asbron (TN) |
(P) Enzyme: CYP1A2 / CYP inhibition: CYP1A2 |
| D06143 |
Tifurac sodium (USAN) |
(P) unclassified |
| D06156 |
Tiopinac (USAN/INN) |
(P) unclassified |
| D06199 |
Trabectedin (JAN/USAN/INN); Yondelis (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D06231 |
Triflubazam (USAN/INN) |
(P) unclassified |
| D06258 |
Tulathromycin (JAN/USAN/INN) |
(P) unclassified |
| D06273 |
Imidafenacin (JAN/INN); Uritos (TN); Staybla (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D06291 |
Verofylline (USAN/INN) |
(P) unclassified |
| D06315 |
Fluticasone furoate (JAN/USAN/INN); Veramyst (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D06334 |
Xanthinol niacinate (USAN); Xantinol nicotinate; Complamin (TN) |
(P) unclassified |
| D06363 |
Ziconotide (USAN/INN); Prialt (TN) |
(P) unclassified |
| D06364 |
Zidometacin (USAN/INN) |
(P) unclassified |
| D06367 |
Zimeldine hydrochloride (USAN); Zimeldine hydrochloride hydrate |
(P) unclassified |
| D06373 |
Zinoconazole hydrochloride (USAN) |
(P) unclassified |
| D06382 |
Zomepirac sodium (USAN); Zomepirac sodium dihydrate |
(P) unclassified |
| D06390 |
Azithromycin (USP); Zmax (TN) |
(P) unclassified |
| D06402 |
Sunitinib malate (JAN/USAN); Sutent (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D06405 |
Nalfurafine hydrochloride (JAN/USAN); Remitch (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D06413 |
Nilotinib hydrochloride hydrate (JAN); Nilotinib monohydrochloride monohydrate; Tasigna (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D06414 |
Dasatinib (USAN); Dasatinib hydrate (JAN); Sprycel (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D06478 |
Darunavir ethanolate (JAN); Prezista (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D06573 |
Carisbamate (USAN) |
(P) unclassified |
| D06597 |
Fosaprepitant dimeglumine (USAN); Fosaprepitant meglumine (JAN); Proemend (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D06598 |
Gamithromycin (USAN/INN) |
(P) unclassified |
| D06606 |
Ibuprofen lysine (USAN); Ibuprofen L-lysine (JAN); Solufenum; Neoprofen (TN) |
(P) CYP inhibition: CYP2C9 |
| D06622 |
Nebivolol hydrochloride (USAN); Bystolic (TN) |
(P) CYP inhibition: CYP2D6 |
| D06630 |
Pramiconazole (USAN/INN) |
(P) unclassified |
| D06635 |
Rilonacept (USAN/INN); Arcalyst (TN) |
(P) unclassified |
| D06637 |
Romidepsin (JAN/USAN/INN); Istodax (TN) |
(P) unclassified |
| D06646 |
Epanolol (USAN/INN) |
(P) unclassified |
| D06883 |
Sertaconazole (INN) |
(P) unclassified |
| D06886 |
Natalizumab (USAN/INN); Natalizumab (genetical recombination) (JAN); Natalizumab-sztn; Tysabri (TN); Tyruko (TN) |
(P) unclassified |
| D07062 |
Acefylline piperazine (INN); Epicophylline (TN) |
(P) unclassified |
| D07064 |
Acenocoumarol (INN); Acenocoumarin; Mini-sintrom (TN) |
(P) unclassified |
| D07131 |
Ethyl biscoumacetate (INN) |
(P) unclassified |
| D07135 |
Clorindione (INN); G-25766 |
(P) unclassified |
| D07136 |
Diphenadione (INN) |
(P) unclassified |
| D07137 |
Tioclomarol (INN) |
(P) unclassified |
| D07139 |
Cloricromen (INN) |
(P) unclassified |
| D07141 |
Indobufen (INN) |
(P) unclassified |
| D07151 |
Cafedrine (BAN) |
(P) unclassified |
| D07155 |
Theodrenaline (INN) |
(P) unclassified |
| D07156 |
Alprenolol (INN) |
(P) CYP inhibition: CYP2D6 |
| D07174 |
Pentifylline (INN) |
(P) unclassified |
| D07181 |
Mepindolol (INN) |
(P) unclassified |
| D07182 |
Tertatolol (INN) |
(P) unclassified |
| D07183 |
Cloranolol (INN) |
(P) unclassified |
| D07184 |
Talinolol (INN) |
(P) unclassified |
| D07185 |
Fendiline (INN) |
(P) unclassified |
| D07193 |
Flutrimazole (INN) |
(P) unclassified |
| D07217 |
Quinagolide (INN/BAN) |
(P) unclassified |
| D07218 |
Metergoline (INN) |
(P) unclassified |
| D07219 |
Flunoxaprofen (INN) |
(P) unclassified |
| D07242 |
Flurithromycin (INN) |
(P) unclassified |
| D07262 |
Mofebutazone (INN); Monazone (TN) |
(P) unclassified |
| D07263 |
Clofezone (JAN/INN); Clofezone dihydrate |
(P) unclassified |
| D07264 |
Bumadizone (INN) |
(P) unclassified |
| D07265 |
Lonazolac (INN) |
(P) unclassified |
| D07266 |
Oxametacin (INN) |
(P) unclassified |
| D07267 |
Droxicam (INN) |
(P) unclassified |
| D07268 |
Ibuproxam (INN); Ibudros (TN) |
(P) unclassified |
| D07269 |
Dexketoprofen (INN) |
(P) unclassified |
| D07283 |
Esketamine (USAN/INN) |
(P) Enzyme: CYP2C19 CYP3A4 / CYP inhibition: CYP3A4 CYP2C19 |
| D07290 |
Dipyrocetyl (INN) |
(P) unclassified |
| D07291 |
Benorilate (INN); Benorylate |
(P) unclassified |
| D07292 |
Guacetisal (INN); Prontomucil (TN) |
(P) unclassified |
| D07293 |
Imidazole salicylate (INN); Selezen (TN) |
(P) unclassified |
| D07298 |
Barbexaclone (INN); Maliasin (TN) |
(P) unclassified |
| D07299 |
Lacosamide (JAN/USAN/INN); Erlosamide; Vimpat (TN) |
(P) Enzyme: CYP2C19 CYP3A4 / CYP inhibition: CYP3A4 CYP2C19 CYP2C9 |
| D07300 |
Beclamide (INN) |
(P) unclassified |
| D07314 |
Pinazepam (INN); Domar (TN) |
(P) unclassified |
| D07315 |
Camazepam (INN) |
(P) unclassified |
| D07326 |
Loprazolam (INN); Dormonoct (TN) |
(P) unclassified |
| D07327 |
Doxefazepam (INN) |
(P) unclassified |
| D07328 |
Cinolazepam (INN); Gerodorm (TN) |
(P) unclassified |
| D07335 |
Amineptine (INN); Survector (TN) |
(P) unclassified |
| D07336 |
Quinupramine (INN) |
(P) unclassified |
| D07337 |
Nialamide (INN); Niamid (TN) |
(P) unclassified |
| D07338 |
Iproclozide (INN) |
(P) unclassified |
| D07339 |
Oxitriptan (INN); Levothym (TN) |
(P) unclassified |
| D07340 |
Oxaflozane (INN) |
(P) unclassified |
| D07341 |
Medifoxamine (INN) |
(P) unclassified |
| D07342 |
Pivagabine (INN) |
(P) unclassified |
| D07378 |
Etamiphylline (INN) |
(P) unclassified |
| D07421 |
Aloxiprin (INN); Superpyrin (TN) |
(P) unclassified |
| D07436 |
Afelimomab (INN) |
(P) unclassified |
| D07443 |
Amfenac (INN) |
(P) unclassified |
| D07448 |
Amitriptyline (INN); Laroxyl (TN) |
(P) Enzyme: CYP2C19 CYP3A4 / CYP inhibition: CYP3A4 CYP2D6 CYP2C19 |
| D07450 |
Amlodipine (USP/INN); Norvasc (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D07453 |
Amtolmetin guacil (INN); Artromed (TN) |
(P) unclassified |
| D07457 |
Anisindione (INN); Miradon (TN) |
(P) unclassified |
| D07471 |
Atazanavir (INN); Reyataz (TN) |
(P) CYP inhibition: CYP3A4 |
| D07474 |
Atorvastatin (INN); Lipitor (TN); Sortis (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D07486 |
Azithromycin (INN); Azasite (TN) |
(P) unclassified |
| D07488 |
Balsalazide (INN) |
(P) unclassified |
| D07491 |
Bamifylline (INN) |
(P) unclassified |
| D07494 |
Barnidipine (INN); Vasexten (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D07496 |
Befunolol (INN) |
(P) unclassified |
| D07503 |
Bendazac lysine (BAN); Bendalina (TN) |
(P) unclassified |
| D07505 |
Latanoprost and timolol maleate; Xalacom (TN) |
(P) unclassified |
| D07509 |
Benidipine (INN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D07516 |
Benzydamine (INN) |
(P) unclassified |
| D07517 |
Benzydamine salicylate; Fulgium (TN) |
(P) unclassified |
| D07520 |
Bepridil (INN); Bepadin (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 CYP2D6 CYP2C9 |
| D07523 |
Betaine (JAN); Cystadane (TN) |
(P) unclassified |
| D07526 |
Betaxolol (INN) |
(P) unclassified |
| D07528 |
Bifemelane (INN) |
(P) unclassified |
| D07537 |
Bopindolol (INN); Sandonorm (TN) |
(P) CYP inhibition: CYP2D6 |
| D07541 |
Bromfenac (INN) |
(P) unclassified |
| D07545 |
Brovincamine (INN); Sarbromin (TN) |
(P) unclassified |
| D07549 |
Bumadizone calcium salt hemihydrate; Desflam (TN); Eumotol (TN) |
(P) unclassified |
| D07569 |
Candesartan cilexetil and anmlodipine besylate (JP19); Unisia (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D07579 |
Aspirin calcium salt; Notras (TN) |
(P) unclassified |
| D07580 |
Aspirin DL-lysine (JAN); Aspirin lysine salt; Aspegic (TN) |
(P) unclassified |
| D07581 |
Aspirin magnesium salt; Mobidin (TN) |
(P) unclassified |
| D07582 |
Aspirin sodium; Sodium acetylsalicylate; Catalgine (TN) |
(P) unclassified |
| D07583 |
Phenytoin and phenobarbital; Aleviatin with phenobarbital (TN) |
(P) CYP inhibition: CYP2C9 |
| D07585 |
Isopropylantipyrine, ergotamine tartrate and anhydrous caffeine; Cleamine A (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D07590 |
Bupranolol (INN) |
(P) unclassified |
| D07591 |
Bupropion (INN) |
(P) unclassified |
| D07595 |
Fosphenytoin sodium hydrate (JAN); Fostoin (TN) |
(P) CYP inhibition: CYP2C9 / CYP induction: CYP3A4 |
| D07598 |
Butoconazole (INN); Gynofort (TN) |
(P) unclassified |
| D07601 |
Butriptyline (INN); Evadyne (TN) |
(P) unclassified |
| D07603 |
Caffeine citrate (USP); Cafcit (TN) |
(P) Enzyme: CYP1A2 / CYP inhibition: CYP1A2 |
| D07608 |
Carazolol (INN); Conducton (TN); Suacron [veterinary] (TN) |
(P) unclassified |
| D07612 |
Sodium salamidacetate; o-Carbamoylphenoxyacetic acid sodium salt; Clinit-n (TN) |
(P) unclassified |
| D07624 |
Carteolol (INN) |
(P) CYP inhibition: CYP2D6 |
| D07660 |
Celiprolol (INN) |
(P) unclassified |
| D07661 |
Cerivastatin (INN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D07676 |
Chlormidazole hydrochloride; Unfungicid (TN) |
(P) unclassified |
| D07704 |
Citalopram (USP/INN); Citadur (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 CYP2D6 CYP2C19 |
| D07705 |
Citalopram hydrochloride; Seropram (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 CYP2D6 CYP2C19 |
| D07710 |
Clarithromycin lactobionate; Klacid (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D07714 |
Climazolam (INN); Climasol [veterinary] (TN) |
(P) unclassified |
| D07727 |
Clomipramine (INN); Anafranil (TN) |
(P) Enzyme: CYP2C19 CYP3A4 / CYP inhibition: CYP3A4 CYP2D6 CYP2C19 |
| D07736 |
Cloricromen hydrohloride; Proendotel (TN) |
(P) unclassified |
| D07752 |
Croconazole (INN) |
(P) unclassified |
| D07784 |
Delorazepam (INN); Dadumir (TN) |
(P) unclassified |
| D07791 |
Desipramine (INN) |
(P) unclassified |
| D07793 |
Desvenlafaxine (INN); Khedezla (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D07812 |
Dibenzepin (INN) |
(P) unclassified |
| D07816 |
Diclofenac (USAN/INN); Solaraze (TN); Zorvolex (TN) |
(P) CYP inhibition: CYP2C9 |
| D07817 |
Diclofenac diethylamine; Voltaren Emulgel (TN) |
(P) CYP inhibition: CYP2C9 |
| D07818 |
Diclofenac epolamine; Diclofenac hydroxyethylpyrrolidine; Flector (TN) |
(P) CYP inhibition: CYP2C9 |
| D07819 |
Diclofenac calcium; Voltaren Actingo Extra (TN) |
(P) CYP inhibition: CYP2C9 |
| D07824 |
Diethylamine salicylate; Algesal (TN) |
(P) unclassified |
| D07833 |
Dihydroergocristine mesilate (BAN); Diertine (TN) |
(P) unclassified |
| D07834 |
Dihydroergocristine (BAN) |
(P) unclassified |
| D07835 |
Dihydroergocryptine |
(P) unclassified |
| D07836 |
Dihydroergocryptine mesilate; Almirid (TN) |
(P) unclassified |
| D07837 |
Dihydroergotamine (INN); Neomigran (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D07838 |
Dihydroergotamine tartrate; Divegal (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D07839 |
Dihydroergotoxine; Co-Dergocrin (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D07845 |
Diltiazem (INN); Surazem (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D07862 |
Diphenylpyraline (INN) |
(P) unclassified |
| D07869 |
Donepezil (JAN/INN); Donaz (TN); Allydone (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D07872 |
Dosulepin (INN); Dothiepin; Dothep (TN) |
(P) CYP inhibition: CYP2D6 |
| D07875 |
Doxepin (INN); Sinequan (TN) |
(P) Enzyme: CYP2C19 / CYP inhibition: CYP2D6 CYP2C19 CYP2C9 |
| D07880 |
Duloxetine (INN); Yentreve (TN) |
(P) Enzyme: CYP1A2 / CYP inhibition: CYP1A2 |
| D07882 |
Eberconazole (INN) |
(P) unclassified |
| D07884 |
Eberconazole nitrate; Ebernet (TN) |
(P) unclassified |
| D07886 |
Efonidipine (INN) |
(P) unclassified |
| D07888 |
Eltenac (INN); Telzenac (TN) |
(P) unclassified |
| D07905 |
Ergometrine (INN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D07906 |
Ergotamine (INN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D07909 |
Erythromycin thiocyanate; Erythrocin (TN) |
(P) unclassified |
| D07910 |
Erythromycin stinoprate (INN); Erysec (TN) |
(P) unclassified |
| D07913 |
Escitalopram (INN); Esertia (TN) |
(P) Enzyme: CYP2C19 CYP3A4 / CYP inhibition: CYP3A4 CYP2D6 CYP2C19 |
| D07916 |
Esmolol (INN) |
(P) unclassified |
| D07917 |
Esomeprazole (INN); Inexium paranova (TN) |
(P) Enzyme: CYP2C19 / CYP inhibition: CYP2C19 |
| D07923 |
Etamiphylline hydrochloride; Solufilina (TN) |
(P) unclassified |
| D07933 |
Etofylline (INN); Oxyphyllin (TN) |
(P) unclassified |
| D07938 |
Bupropion hydrobromide (USAN); Aplenzin (TN) |
(P) unclassified |
| D07943 |
Fendiline hydrochloride; Sensit (TN) |
(P) unclassified |
| D07944 |
Fenetylline (INN); Fenethylline; Fitton (TN) |
(P) unclassified |
| D07945 |
Fenfluramine (INN); Ponderax (TN) |
(P) Enzyme: CYP1A2 CYP2C19 CYP3A4 / CYP inhibition: CYP1A2 CYP3A4 CYP2D6 CYP2C19 |
| D07969 |
Fluindione (INN); Previsccan (TN) |
(P) unclassified |
| D07971 |
Flunarizine (INN); Sibelium (TN) |
(P) CYP inhibition: CYP2D6 |
| D07983 |
Fluvastatin (INN); Fluvas (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 CYP2C9 |
| D07984 |
Fluvoxamine (INN) |
(P) CYP inhibition: CYP2D6 CYP1A2 CYP2C19 CYP3A4 |
| D07991 |
Fosfosal (INN); Aydolid (TN) |
(P) unclassified |
| D07993 |
Fosphenytoin (INN) |
(P) CYP inhibition: CYP2C9 / CYP induction: CYP3A4 |
| D08009 |
Gallopamil (INN) |
(P) unclassified |
| D08021 |
Glucametacin (INN); Glucametan (TN) |
(P) unclassified |
| D08032 |
Gusperimus (INN); 15-Deoxyspergualin |
(P) unclassified |
| D08035 |
Haloperidol lactate; Haldol (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 CYP2D6 |
| D08058 |
Ibuprofen arginine salt; Zafen (TN) |
(P) CYP inhibition: CYP2C9 |
| D08059 |
Ibuprofen sodium; Ibuprofen sodium anhydrous; Esprenit (TN) |
(P) CYP inhibition: CYP2C9 |
| D08070 |
Imipramine (INN); Tofranil (TN) |
(P) Enzyme: CYP2C19 CYP3A4 / CYP inhibition: CYP3A4 CYP2D6 CYP2C19 |
| D08071 |
Imipramine pamoate (USP); Imipramine embonate; Tofranil-pm (TN) |
(P) Enzyme: CYP2C19 CYP3A4 / CYP inhibition: CYP3A4 CYP2D6 CYP2C19 |
| D08074 |
Penbutolol (INN) |
(P) unclassified |
| D08078 |
Indenolol (INN) |
(P) unclassified |
| D08083 |
Vedolizumab (USAN); Vedolizumab (genetical recombination) (JAN); Entyvio (TN) |
(P) unclassified |
| D08085 |
Iproniazid phosphate; Marsilid (TN) |
(P) unclassified |
| D08095 |
Ivabradine hydrochloride (JAN/USAN); Ivabrandine hydrochloride; Corlanor (TN); Corlentor (TN); Coralan (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D08102 |
Ketoprofen lysine; Artrosilene (TN) |
(P) unclassified |
| D08103 |
Ketoprofen sodium; Orudis (TN) |
(P) unclassified |
| D08104 |
Ketorolac (INN); Toradol (TN) |
(P) unclassified |
| D08111 |
Lercanidipine (INN); Lercanil (TN) |
(P) unclassified |
| D08115 |
Levobunolol (INN) |
(P) unclassified |
| D08132 |
Lisuride (INN) |
(P) unclassified |
| D08140 |
Lofepramine (INN) |
(P) unclassified |
| D08142 |
Lonazolac calcium salt; Argun (TN) |
(P) unclassified |
| D08145 |
Loprazolam mesilate; Loprazolam mesylate; Loprazolam methanesulfonate; Havlane (TN) |
(P) unclassified |
| D08149 |
Loxoprofen (INN) |
(P) unclassified |
| D08153 |
Mabuprofen (INN); Aldospray analgesico (TN) |
(P) unclassified |
| D08155 |
Manidipine (INN); Manidipine 6300; Artedil (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D08162 |
Meclofenamate sodium; Meclomen (TN) |
(P) unclassified |
| D08170 |
Melatonin (JAN); Melatonina (TN); Melatobel (TN) |
(P) Enzyme: CYP1A2 / CYP inhibition: CYP1A2 |
| D08171 |
Melitracen (INN); Adelax (TN) |
(P) unclassified |
| D08190 |
Dipyrone (BAN); Metamizole sodium; Vetalgin (TN) |
(P) unclassified |
| D08207 |
Methylergometrine (INN); Ergotyl (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D08216 |
Mianserin (INN); Tolvon (TN) |
(P) Enzyme: CYP1A2 CYP3A4 / CYP inhibition: CYP1A2 CYP3A4 CYP2D6 |
| D08217 |
Mibefradil (INN) |
(P) CYP inhibition: CYP1A2 |
| D08222 |
Milnacipran (INN) |
(P) unclassified |
| D08257 |
Nefazodone (INN) |
(P) unclassified |
| D08259 |
Nelfinavir (INN); Viracept (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D08270 |
Nicardipine (INN); Cardene (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D08271 |
Nicergoline tartrate; Sermion (TN) |
(P) unclassified |
| D08275 |
Niflumic acid (INN); Niflugel (TN) |
(P) unclassified |
| D08283 |
Nordazepam (INN); Calmday (TN) |
(P) Enzyme: CYP2C19 CYP3A4 / CYP inhibition: CYP3A4 CYP2C19 |
| D08288 |
Nortriptyline (INN); Nortrilen (TN) |
(P) CYP inhibition: CYP2D6 |
| D08295 |
Olsalazine (INN) |
(P) unclassified |
| D08296 |
Omoconazole (INN) |
(P) unclassified |
| D08297 |
Opipramol (INN) |
(P) unclassified |
| D08313 |
Oxiconazole (INN) |
(P) unclassified |
| D08318 |
Oxprenolol (INN) |
(P) unclassified |
| D08324 |
Oxyphenbutazone (INN); Reozon (TN) |
(P) unclassified |
| D08339 |
Pergolide (INN); Permax (TN) |
(P) unclassified |
| D08340 |
Perhexiline (INN) |
(P) CYP inhibition: CYP2D6 |
| D08349 |
Phenelzine (BAN) |
(P) unclassified |
| D08354 |
Phenindione (INN); Hedulin (TN) |
(P) unclassified |
| D08356 |
Phenobarbital diethylamine; Gratusminal (TN) |
(P) unclassified |
| D08363 |
Phenylbutazone calcium; Peralgin (TN) |
(P) unclassified |
| D08364 |
Phenylbutazone sodium; Ambene (TN) |
(P) unclassified |
| D08374 |
Piketoprofen (INN); Calmatel (TN) |
(P) unclassified |
| D08375 |
Piketoprofen hydrochloride; Triparsean (TN) |
(P) unclassified |
| D08410 |
Pravastatin (INN); Pravator (TN) |
(P) unclassified |
| D08427 |
Proglumetacin (INN); Bruxel (TN) |
(P) unclassified |
| D08443 |
Propranolol (INN) |
(P) Enzyme: CYP1A2 CYP2C19 / CYP inhibition: CYP1A2 CYP2D6 CYP2C19 |
| D08447 |
Protriptyline (INN) |
(P) unclassified |
| D08457 |
Quinagolide hydrochloride (BAN); Norprolac (TN) |
(P) unclassified |
| D08463 |
Rabeprazole (INN); Eraloc (TN) |
(P) Enzyme: CYP2C19 CYP3A4 / CYP inhibition: CYP3A4 CYP2C19 |
| D08472 |
Reboxetine (INN); Edronax (TN) |
(P) unclassified |
| D08481 |
Rilmazafone (INN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D08488 |
Amlodipine besilate and atorvastatin calcium; Caduet (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D08492 |
Rosuvastatin (INN); Creston (TN) |
(P) unclassified |
| D08493 |
Dorzolamide hydrochloride and timolol maleate (JP19); Cosopt (TN) |
(P) Enzyme: CYP2C19 CYP3A4 / CYP inhibition: CYP3A4 CYP2D6 CYP2C19 CYP2C9 |
| D08497 |
Rupatadine fumarate (JAN/USAN); Rinialer (TN); Rupafin (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D08501 |
Trolamine salicylate (USP); Salicylic acid trolamine; Salicylic acid triethanolamine; Arthricream (TN) |
(P) unclassified |
| D08510 |
Sertaconazole nitrate; Ertaczo (TN); Zalain (TN) |
(P) unclassified |
| D08525 |
Sotalol (INN); Darob mite (TN) |
(P) unclassified |
| D08527 |
Spiramycin adipate; Rovamycina (TN); Spiramaicina (TN) |
(P) unclassified |
| D08528 |
Spiramycin embonate; Cofamix STS (TN) |
(P) unclassified |
| D08535 |
Sulconazole (INN) |
(P) unclassified |
| D08556 |
Tacrolimus (INN); Prograf (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D08572 |
Tertatolol hydrochloride; Artex (TN) |
(P) unclassified |
| D08575 |
Tetrabenazine (JAN/INN); Nitoman (TN); Xenazine (TN) |
(P) Enzyme: CYP1A2 / CYP inhibition: CYP1A2 CYP2D6 |
| D08586 |
Thiosalicylic acid; Pirosal (TN); Thiocyl (TN) |
(P) unclassified |
| D08588 |
Tiagabine (INN); Gabitril (TN) |
(P) unclassified |
| D08589 |
Tianeptine sodium; Stablon (TN) |
(P) unclassified |
| D08592 |
Tiaramide (INN) |
(P) unclassified |
| D08598 |
Tilisolol (INN) |
(P) unclassified |
| D08600 |
Timolol (INN); Betimol (TN) |
(P) CYP inhibition: CYP2D6 |
| D08605 |
Tipranavir (INN); Aptivus (TN) |
(P) unclassified |
| D08625 |
Tranylcypromine (INN); Parnate (TN) |
(P) unclassified |
| D08626 |
Trazodone (INN); Trittico (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 CYP2D6 |
| D08630 |
Tribuzone (prop.INN); Benetazon (TN) |
(P) unclassified |
| D08657 |
Apricoxib (USAN/INN) |
(P) unclassified |
| D08667 |
Calcium valproate; Valproic acid calcium salt; Convulsofin (TN) |
(P) unclassified |
| D08670 |
Venlafaxine (INN); Efectin (TN) |
(P) CYP inhibition: CYP2D6 |
| D08673 |
Viloxazine (INN) |
(P) CYP inhibition: CYP2D6 |
| D08682 |
Warfarin (INN); Warfarine; Choice (TN) |
(P) CYP inhibition: CYP2C9 |
| D08686 |
Ziconotide acetate; Prialt (TN) |
(P) unclassified |
| D08699 |
Salmeterol xinafoate and fluticasone propionate; Adoair diskus (TN); Aerivio Spiromax (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D08856 |
Anamorelin hydrochloride (JAN/USAN); Adlumiz (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D08860 |
Apremilast (JAN/USAN); Otezla (TN) |
(P) unclassified |
| D08879 |
Brivaracetam (JAN/USAN/INN); Briviact (TN) |
(P) Enzyme: CYP2C19 / CYP inhibition: CYP2C19 |
| D08892 |
Clevidipine (USAN/INN); Clevidipine butyrate; Cleviprex (TN) |
(P) unclassified |
| D08903 |
Dexlansoprazole (INN/USAN); Dexilant (TN) |
(P) Enzyme: CYP2C19 CYP3A4 / CYP inhibition: CYP3A4 CYP2C19 |
| D08923 |
Fesoterodine fumarate (JAN/USAN); Toviaz (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 CYP2D6 |
| D08962 |
Pamabrom (USP) |
(P) unclassified |
| D08964 |
Perampanel (JAN/USAN); Fycompa (TN) |
(P) unclassified |
| D08976 |
Pomalidomide (JAN/USAN/INN); Pomalyst (TN) |
(P) Enzyme: CYP1A2 CYP3A4 / CYP inhibition: CYP1A2 CYP3A4 |
| D08989 |
Rolofylline (USAN) |
(P) unclassified |
| D09017 |
Ticagrelor (JAN/USAN/INN); Brilinta (TN) |
(CI,P) unclassified |
| D09033 |
Voclosporin (JAN/USAN/INN); Lupkynis (TN) |
(CI,P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D09188 |
Estradiol and norethindrone; Menoaid (TN); Activella (TN); Combipatch (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D09190 |
Anti-human thymocyte immunoglobulin, rabbit (JAN); Thymoglobuline (TN) |
(P) unclassified |
| D09214 |
Ustekinumab (USAN/INN); Ustekinumab (genetical recombination) (JAN); Ustekinumab (genetical recombination) [Ustekinumab biosimilar 1] (JAN); Ustekinumab (genetical recombination) [Ustekinumab biosimilar 2] (JAN); Ustekinumab (genetical recombination) [Ustekinumab biosimilar 3] (JAN); Ustekinumab (genetical recombination) [Ustekinumab biosimilar 4] (JAN); Ustekinumab-aauz; Ustekinumab-auub; Ustekinumab-ttwe; Ustekinumab-aekn; Ustekinumab-srlf; Ustekinumab-hmny; Stelara (TN); Otulfi (TN); Pyzchiva (TN); Wezlana (TN) |
(P) unclassified |
| D09215 |
Eslicarbazepine (USAN/INN) |
(P) CYP inhibition: CYP2C19 / CYP induction: CYP3A4 |
| D09314 |
Ofatumumab (USAN/INN); Ofatumumab (genetical recombination) (JAN); Arzerra (TN); Kesimpta (TN) |
(P) unclassified |
| D09315 |
Canakinumab (USAN/INN); Canakinumab (genetical recombination) (JAN); Ilaris (TN) |
(P) unclassified |
| D09319 |
Indacaterol maleate (JAN/USAN); Arcapta (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D09339 |
Esomeprazole potassium (USAN) |
(P) Enzyme: CYP2C19 / CYP inhibition: CYP2C19 |
| D09348 |
Fostamatinib disodium (USAN); Fostamatinib sodium hydrate (JAN); Fostamatinib disodium hexahydrate; Tavalisse (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D09365 |
Palovarotene (JAN/USAN/INN); Sohonos (TN) |
(CI,P) Enzyme: CYP2C19 CYP3A4 / CYP inhibition: CYP3A4 CYP2C19 |
| D09394 |
Fidaxomicin (JAN/USAN); Dificid (TN); Dificlir (TN) |
(P) CYP inhibition: CYP2C19 CYP3A4 |
| D09568 |
Naproxcinod (USAN/INN) |
(P) unclassified |
| D09569 |
Ezogabine (USAN); Retigabine (INN); Potiga (TN) |
(P) unclassified |
| D09572 |
Riociguat (JAN/USAN/INN); Adempas (TN) |
(P) unclassified |
| D09587 |
Brentuximab vedotin (USAN/INN); Brentuximab vedotin (genetical recombination) (JAN); Adcetris (TN) |
(P) unclassified |
| D09588 |
Briakinumab (USAN/INN) |
(P) unclassified |
| D09595 |
Budesonide and formoterol fumarate dihydrate; Symbicort (TN); Budeforu (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D09612 |
Eslicarbazepine acetate (USAN); Zebinix (TN); Aptiom (TN) |
(P) CYP inhibition: CYP2C19 / CYP induction: CYP3A4 |
| D09638 |
Lomitapide mesylate (USAN); Lomitapide mesilate (JAN); Juxtapid (TN); Lojuxta (TN) |
(CI,P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D09642 |
Modithromycin (USAN/INN) |
(P) unclassified |
| D09669 |
Siltuximab (USAN/INN); Sylvant (TN) |
(P) unclassified |
| D09676 |
Tecarfarin (USAN/INN) |
(P) unclassified |
| D09677 |
Tecarfarin sodium (USAN) |
(P) unclassified |
| D09680 |
Teprotumumab (USAN/INN); Teprotumumab (genetical recombination) (JAN); Teprotumumab-trbw; Tepezza (TN) |
(P) unclassified |
| D09684 |
Tonapofylline (USAN/INN) |
(P) unclassified |
| D09698 |
Vilazodone (USAN/INN) |
(P) Enzyme: CYP2C19 CYP3A4 / CYP inhibition: CYP3A4 CYP2C19 |
| D09699 |
Vilazodone hydrochloride (USAN); Viibryd (TN) |
(P) Enzyme: CYP2C19 CYP3A4 / CYP inhibition: CYP3A4 CYP2C19 |
| D09702 |
Albaconazole (USAN/INN) |
(P) unclassified |
| D09728 |
Bosutinib hydrate (JAN); Bosutinib monohydrate; Bosulif (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D09730 |
Olaparib (JAN/USAN/INN); Lynparza (TN) |
(P) unclassified |
| D09731 |
Crizotinib (JAN/USAN/INN); Xalkori (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D09743 |
Telmisartan and amlodipine besilate (JP19); Telmisartan and amlodipine besylate; Micamlo (TN); Twynsta (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D09745 |
Valsartan and amlodipine besilate; Exforge (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D09753 |
Saxagliptin hydrate (JAN); Onglyza (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D09760 |
Ibuprofen sodium (USAN); Ibuprofen sodium hydrate |
(P) CYP inhibition: CYP2C9 |
| D09783 |
Tofacitinib citrate (JAN/USAN); Tasocitinib citrate; Xeljanz (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D09789 |
Kirenidipine hydrochloride (JAN) |
(P) unclassified |
| D09799 |
Carotegrast methyl (JAN); Carogra (TN) |
(P) CYP inhibition: CYP3A4 |
| D09807 |
Difethiarol (JAN); Difethialone |
(P) unclassified |
| D09809 |
Tylosin acetate isovalerte (JAN) |
(P) unclassified |
| D09813 |
Lenalidomide hydrate (JAN); Revlimid (TN) |
(P) unclassified |
| D09815 |
Travoprost and timolol maleate; Duotrav (TN) |
(P) unclassified |
| D09837 |
Penaprazole sodium hydrate (JAN) |
(P) unclassified |
| D09843 |
Beradilol monoethyl maleate (JAN); TZC-5665 |
(P) unclassified |
| D09894 |
Eliglustat tartrate (JAN/USAN); Eliglustat hemitartrate; Cerdelga (TN) |
(CI,P) CYP inhibition: CYP2D6 |
| D09951 |
Ponatinib hydrochloride (JAN/USAN); Iclusig (TN) |
(P) unclassified |
| D09956 |
Quizartinib dihydrochloride (USAN); Quizartinib hydrochloride (JAN); Vanflyta (TN) |
(P) unclassified |
| D09960 |
Ruxolitinib phosphate (JAN/USAN); Jakafi (TN); Jakavi (TN); Opzelura (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D09967 |
Secukinumab (USAN/INN); Secukinumab (genetical recombination) (JAN); Cosentyx (TN) |
(P) unclassified |
| D09970 |
Tofacitinib (USAN); Tasocitinib |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D09996 |
Vemurafenib (JAN/USAN/INN); Zelboraf (TN) |
(P) CYP inhibition: CYP1A2 / CYP induction: CYP3A4 |
| D10001 |
Fingolimod (INN); Gilenya (TN) |
(P) unclassified |
| D10003 |
Hemin (JAN); Normosang (TN); Panhematin (TN) |
(P) CYP induction: CYP3A4 |
| D10017 |
Naproxen etemesil (USAN) |
(P) unclassified |
| D10021 |
Efinaconazole (JAN/USAN/INN); Clenafin (TN); Jublia (TN) |
(P) unclassified |
| D10024 |
Selumetinib sulfate (JAN/USAN); Koselugo (TN) |
(P) Enzyme: CYP1A2 CYP3A4 / CYP inhibition: CYP1A2 CYP3A4 CYP2C9 |
| D10032 |
Tylvalosin (USAN/INN) |
(P) unclassified |
| D10033 |
Tylosin tartrate (USP) |
(P) unclassified |
| D10034 |
Tylvalosin tartrate (USAN); Aiviosin [veterinary] (TN) |
(P) unclassified |
| D10061 |
Brodalumab (USAN); Brodalumab (genetical recombination) (JAN); Siliq (TN) |
(P) unclassified |
| D10071 |
Ixekizumab (USAN); Ixekizumab (genetical recombination) (JAN); Taltz (TN) |
(P) unclassified |
| D10072 |
Levomilnacipran (USAN/INN) |
(P) unclassified |
| D10080 |
Sirukumab (USAN); Sirukumab (genetical recombination) (JAN) |
(P) unclassified |
| D10082 |
Suvorexant (JAN/USAN); MK-4305; Belsomra (TN) |
(P) unclassified |
| D10095 |
Cabozantinib s-malate (USAN); Cabozantinib malate (JAN); Cometriq (TN); Cabometyx (TN) |
(P) unclassified |
| D10104 |
Dabrafenib mesylate (USAN); Dabrafenib mesilate (JAN); Tafinlar (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D10120 |
Esomeprazole strontium (USAN); Esomeprazole strontium tetrahydrate |
(P) Enzyme: CYP2C19 / CYP inhibition: CYP2C19 |
| D10127 |
Glycerol phenylbutyrate (JAN/USAN); Ravicti (TN) |
(P) unclassified |
| D10133 |
Levomilnacipran hydrochloride (USAN); Fetzima (TN) |
(P) unclassified |
| D10135 |
Macitentan (JAN/USAN); Opsumit (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D10137 |
Regorafenib hydrate (JAN); Stivarga (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D10161 |
Sarilumab (USAN); Sarilumab (genetical receombination) (JAN); Kevzara (TN) |
(P) unclassified |
| D10172 |
Teriflunomide (USAN); Aubagio (TN) |
(P) unclassified |
| D10184 |
Vortioxetine (USAN); Brintellix (TN) |
(P) Enzyme: CYP2C19 / CYP inhibition: CYP2D6 CYP2C19 CYP2C9 |
| D10185 |
Vortioxetine hydrobromide (JAN/USAN); Brintellix (TN); Trintellix (TN) |
(P) Enzyme: CYP2C19 / CYP inhibition: CYP2D6 CYP2C19 CYP2C9 |
| D10218 |
Enzalutamide (JAN/USAN); Xtandi (TN) |
(P) unclassified |
| D10223 |
Ibrutinib (JAN/USAN); Imbruvica (TN) |
(P) unclassified |
| D10243 |
Irbesartan and amlodipine besilate (JP19); Aimix (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D10254 |
Esflurbiprofen (JAN/USAN) |
(P) CYP inhibition: CYP2C9 |
| D10298 |
Brimonidine tartrate and timolol maleate; Combigan (TN); Aibeta (TN) |
(P) unclassified |
| D10307 |
Avatrombopag maleate (JAN/USAN); Doptelet (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 CYP2C9 |
| D10308 |
Baricitinib (JAN/USAN/INN); Olumiant (TN) |
(P) unclassified |
| D10309 |
Brexpiprazole (JAN/USAN/INN); Rexulti (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 CYP2D6 |
| D10372 |
Palbociclib (JAN/USAN); Ibrance (TN) |
(P) unclassified |
| D10400 |
Tildrakizumab (USAN); Tildrakizumab (genetical recombination) (JAN); Tildrakizumab-asmn; Ilumya (TN) |
(P) unclassified |
| D10438 |
Guselkumab (USAN/INN); Guselkumab (genetical recombination) (JAN); Tremfya (TN) |
(P) unclassified |
| D10450 |
Alectinib hydrochloride (JAN); Alecensa (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D10452 |
Cabazitaxel acetonate (JAN); Cabazitaxel acetone; Jevtana (TN) |
(P) unclassified |
| D10466 |
Vonoprazan fumarate (JAN/USAN); Takecab (TN); Voquezna (TN) |
(P) Enzyme: CYP2C19 CYP3A4 / CYP inhibition: CYP3A4 CYP2D6 CYP2C19 |
| D10478 |
Naldemedine tosylate (JAN/USAN); Naldemedine tosilate; Symproic (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D10492 |
Tildipirosin (USAN/INN); Zuprevo [veterinary] (TN) |
(P) unclassified |
| D10501 |
Fluticasone furoate and vilanterol trifenatate; Breo ellipta (TN); Relvar ellipita (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D10505 |
Glycopyrronium bromide and indacaterol maleate; Ultibro (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D10506 |
Fluticasone propionate and formoterol fumarate hydrate; Flutiform (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D10512 |
Brinzolamide and timolol maleate; Azorga (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 CYP2D6 CYP2C9 |
| D10513 |
Clopidogrel sulfate and aspirin; Clopidogrel and acetylsalicyclic acid; Complavin (TN) |
(P) Enzyme: CYP2C19 CYP3A4 / CYP inhibition: CYP3A4 CYP2C19 |
| D10516 |
Aripiprazole hydrate (JAN); Aripiprazole monohydrate; Abilify maintena (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 CYP2D6 |
| D10524 |
Azilsartan and amlodipine besilate; Zacras (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D10533 |
Umeclidinium bromide and vilanterol; Anoro (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 CYP2D6 |
| D10551 |
Ceritinib (JAN/USAN/INN); Zykadia (TN) |
(P) unclassified |
| D10564 |
Amenamevir (JAN/INN); Amenalief (TN) |
(P) unclassified |
| D10566 |
Pasireotide pamoate (JAN); Signifor lar (TN) |
(P) unclassified |
| D10568 |
Pitavastatin calcium hydrate (JP19); Pitabastatin calcium pentahydrate; Livalo (TN) |
(P) CYP inhibition: CYP2C9 |
| D10569 |
Tafluprost and timolol maleate; Tapcom (TN) |
(P) unclassified |
| D10627 |
Esketamine hydrochloride (JAN/USAN); Spravato (TN) |
(P) Enzyme: CYP2C19 CYP3A4 / CYP inhibition: CYP3A4 CYP2C19 |
| D10633 |
Finerenone (JAN/USAN/INN); Kerendia (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D10643 |
Isavuconazonium sulfate (JAN/USAN); Cresemba (TN) |
(P) unclassified |
| D10653 |
Peficitinib (USAN/INN) |
(P) unclassified |
| D10656 |
Polmacoxib (USAN/INN) |
(P) unclassified |
| D10663 |
Rimegepant sulfate (USAN); Rimegepant sulfate hydrate (JAN); Nurtec odt (TN); Vydura (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D10679 |
Venetoclax (JAN/USAN/INN); Venclexta (TN) |
(CI,P) unclassified |
| D10688 |
Abemaciclib (JAN/USAN/INN); Verzenio (TN) |
(P) unclassified |
| D10721 |
Peficitinib hydrobromide (JAN/USAN); Smyraf (TN) |
(P) unclassified |
| D10746 |
Esflurbiprofen and mentha oil; Loqoa (TN) |
(P) CYP inhibition: CYP2C9 |
| D10750 |
Isavuconazole (INN); Cresemba (TN) |
(P) unclassified |
| D10761 |
Polatuzumab vedotin (USAN); Polatuzumab vedotin (genetical recombination) (JAN); Polatuzumab vedotin-piiq; Polivy (TN) |
(P) unclassified |
| D10762 |
Fosravuconazole L-lysine ethanolate (JAN) |
(P) unclassified |
| D10774 |
Vonoprazan, amoxicillin and metronidazole; Vonopion (TN) |
(P) Enzyme: CYP2C19 CYP3A4 / CYP inhibition: CYP3A4 CYP2D6 CYP2C19 |
| D10775 |
Vonoprazan, amoxicillin and clarithromycin; Vonosap (TN); Voquenza (TN) |
(P) Enzyme: CYP2C19 CYP3A4 / CYP inhibition: CYP3A4 CYP2D6 CYP2C19 |
| D10780 |
Perampanel hydrate (JAN); Fycompa (TN) |
(P) unclassified |
| D10800 |
Gilteritinib fumarate (JAN/USAN); Xospata (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D10801 |
Letermovir (JAN/USAN/INN); Prevymis (TN) |
(P) CYP induction: CYP2C19 |
| D10805 |
Telmisartan, amlodipine and hydrochlorothiazide; Micatrio (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D10866 |
Brigatinib (JAN/USAN); Alunbrig (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D10871 |
Filgotinib (USAN/INN) |
(P) unclassified |
| D10872 |
Filgotinib hydrochloride (USAN) |
(P) unclassified |
| D10891 |
Capmatinib hydrochloride (USAN); Capmatinib hydrochloride hydrate (JAN); Tabrecta (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D10892 |
Esaxerenone (JAN/INN) |
(P) unclassified |
| D10893 |
Acalabrutinib (JAN/USAN/INN); Calquence (TN) |
(P) unclassified |
| D10915 |
Cannabidiol (JAN/USAN/INN); CBD; Epidiolex (TN) |
(P) Enzyme: CYP2C19 CYP3A4 / CYP inhibition: CYP3A4 CYP2C19 |
| D10926 |
Entrectinib (JAN/USAN/INN); Rozlytrek (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D10927 |
Erdafitinib (JAN/USAN/INN); Balversa (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 CYP2C9 |
| D10930 |
Etrasimod (USAN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 CYP2C9 |
| D10931 |
Etrasimod arginine (USAN); Etrasimod L-arginine (JAN); Velsipity (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 CYP2C9 |
| D10932 |
Etripamil (USAN/INN); Cardamyst (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D10944 |
Itacitinib (USAN/INN) |
(P) unclassified |
| D10945 |
Itacitinib adipate (JAN/USAN) |
(P) unclassified |
| D10967 |
Ozanimod hydrochloride (JAN/USAN); Zeposia (TN) |
(P) unclassified |
| D10968 |
Ozanimod (USAN/INN) |
(P) unclassified |
| D10990 |
Somatrogon (USAN/INN); Somatrogon (genetical recombination) (JAN); Somatrogon-ghla; Ngenla (TN) |
(P) unclassified |
| D10993 |
Tucidinostat (JAN/USAN/INN); Hiyasta (TN) |
(P) unclassified |
| D10994 |
Upadacitinib (USAN/INN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D10995 |
Upadacitinib tartrate (USAN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D10999 |
Valbenazine tosylate (USAN); Valbenazine tosilate (JAN); Valbenazine ditosylate; Ingrezza (TN); Dysval (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D11012 |
Lorlatinib (JAN/USAN/INN); Lorbrena (TN) |
(P) unclassified |
| D11022 |
Lemborexant (JAN/USAN/INN); Dayvigo (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D11027 |
Ropeginterferon alfa-2b (INN); Ropeginterferon alfa-2b (genetical recombination) (JAN); Ropeginterferon alfa-2b-njft; Besremi (TN) |
(P) unclassified |
| D11035 |
Fluticasone furoate, umeclidinium bromide and vilanterol; Trelegy ellipta (TN) |
(P) unclassified |
| D11040 |
Apalutamide (JAN/INN); Erleada (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 CYP2C19 |
| D11048 |
Upadacitinib hydrate (JAN); Upadacitinib hemihydrate; Rinvoq (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D11052 |
Risankizumab (USAN/INN); Risankizumab (genetical recombination) (JAN); Risankizumab-rzaa; Skyrizi (TN) |
(P) unclassified |
| D11053 |
Encorafenib (JAN/USAN/INN); Braftovi (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D11054 |
Ravulizumab (USAN/INN); Ravulizumab (genetical recombination) (JAN); Ultomiris (TN) |
(P) unclassified |
| D11056 |
Mirtazapine hydrate (JAN) |
(P) Enzyme: CYP1A2 CYP3A4 / CYP inhibition: CYP1A2 CYP3A4 CYP2D6 |
| D11062 |
Osilodrostat phosphate (JAN/USAN); Isturisa (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 CYP2D6 |
| D11070 |
Tirabrutinib hydrochloride (JAN/USAN); Velexbru (TN) |
(P) unclassified |
| D11072 |
Siponimod fumarate (USAN); Siponimod fumaric acid (JAN); Mayzent (TN) |
(P) CYP inhibition: CYP2C9 |
| D11079 |
Satralizumab (USAN/INN); Satralizumab (genetical recombination) (JAN); satralizumab-mwge; Enspryng (TN) |
(P) unclassified |
| D11082 |
Anifrolumab (USAN); Anifrolumab (genetical recombination) (JAN); Anifrolumab-fnia; Saphnelo (TN) |
(P) unclassified |
| D11090 |
Ivosidenib (JAN/USAN/INN); Tibsovo (TN) |
(P) unclassified |
| D11092 |
Pitavastatin magnesium; Zypitamag (TN) |
(P) CYP inhibition: CYP2C9 |
| D11093 |
Avacopan (JAN/USAN/INN); Tavneos (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D11095 |
Atorvastatin calcium propylene glycol solvate |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D11106 |
Filgotinib maleate (JAN/USAN); Jyseleca (TN) |
(P) unclassified |
| D11114 |
Esomeprazole magnesium dihydrate |
(P) Enzyme: CYP2C19 / CYP inhibition: CYP2C19 |
| D11120 |
Emapalumab (USAN/INN); Emapalumab (genetical recombination) (JAN); Emapalumab-lzsg; Gamifant (TN) |
(P) unclassified |
| D11123 |
Mirikizumab (USAN/INN); Mirikizumab (genetical recombination) (JAN); Mirikizumab-mrkz; Omvoh (TN) |
(P) unclassified |
| D11138 |
Larotrectinib sulfate (JAN/USAN); Vitrakvi (TN) |
(P) unclassified |
| D11149 |
Brexanolone (USAN/INN); Zulresso (TN) |
(P) unclassified |
| D11150 |
Cenobamate (JAN/USAN/INN); Xcopri (TN) |
(P) Enzyme: CYP2C19 CYP3A4 / CYP inhibition: CYP3A4 CYP2C19 |
| D11154 |
Diroximel fumarate (JAN/USAN/INN); Vumerity (TN) |
(P) unclassified |
| D11159 |
Leniolisib phosphate (JAN/USAN); Joenja (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D11194 |
Somapacitan (USAN/INN); Somapacitan (genetical recombination) (JAN); Somapacitan-beco; Sogroya (TN) |
(P) unclassified |
| D11215 |
Ponesimod (USAN/INN); Ponvory (TN) |
(P) unclassified |
| D11243 |
Ublituximab (USAN/INN); Briumvi (TN) |
(P) unclassified |
| D11296 |
Fedratinib hydrochloride (USAN); Fedratinib hydrochloride hydrate (JAN); Fedratinib dihydrochloride monohydrate; Inrebic (TN) |
(P) Enzyme: CYP2C19 CYP3A4 / CYP inhibition: CYP3A4 CYP2C19 |
| D11370 |
Fosnetupitant chloride hydrochloride (JAN/USAN); Arokaris (TN) |
(P) unclassified |
| D11371 |
Capivasertib (JAN/USAN); Truqap (TN) |
(P) unclassified |
| D11397 |
Darvadstrocel (INN); Alofisel (TN) |
(P) unclassified |
| D11400 |
Abrocitinib (JAN/USAN); Cibinqo (TN) |
(P) Enzyme: CYP2C19 / CYP inhibition: CYP2C19 CYP2C9 |
| D11417 |
Pemigatinib (JAN/USAN/INN); Pemazyre (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D11422 |
Zanubrutinib (JAN/USAN/INN); Brukinsa (TN) |
(P) unclassified |
| D11454 |
Repotrectinib (JAN/USAN); Augtyro (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D11460 |
Siponimod (USAN/INN) |
(P) CYP inhibition: CYP2C9 |
| D11470 |
Imlifidase (USAN/INN); Idefirix (TN) |
(P) unclassified |
| D11477 |
Pozelimab (USAN); Pozelimab-bbfg; Veopoz (TN) |
(P) unclassified |
| D11485 |
Tazemetostat hydrobromide (JAN/USAN); Tazverik (TN) |
(P) unclassified |
| D11492 |
Monomethyl fumarate (USAN); Bafiertam (TN) |
(P) unclassified |
| D11525 |
Enfortumab vedotin (USAN); Enfortumab vedotin (genetical recombination) (JAN); Enfortumab vedotin-ejfv; Padcev (TN) |
(P) unclassified |
| D11530 |
Sutimlimab (USAN/INN); Sutimlimab (genetical recombination) (JAN); Sutimlimab-jome; Enjaymo (TN) |
(P) unclassified |
| D11550 |
Bimekizumab (USAN/INN); Bimekizumab (genetical recombination) (JAN); Bimzelx (TN) |
(P) unclassified |
| D11557 |
Tecovirimat hydrate (JAN); Tecovirimat monohydrate; Tpoxx (TN); Tepoxx (TN) |
(P) unclassified |
| D11584 |
Budesonide, glycopyrronium bromide and formoterol fumarate; Budesonide, glycopyrrolate and formoterol fumarate; Breztri (TN) |
(P) unclassified |
| D11613 |
Pegcetacoplan (JAN/USAN/INN); Empaveli (TN) |
(P) unclassified |
| D11619 |
Desvenlafaxine succinate anhydrous |
(P) unclassified |
| D11630 |
Aminophylline dihydrate |
(P) Enzyme: CYP1A2 / CYP inhibition: CYP1A2 |
| D11641 |
Danicopan (JAN/USAN/INN); Voydeya (TN) |
(P) unclassified |
| D11659 |
Tolvaptan sodium phosphate (JAN); Samtasu (TN) |
(P) unclassified |
| D11662 |
Valemetostat tosilate (JAN); Valemetostat tosylate; Ezharmia (TN) |
(P) unclassified |
| D11666 |
Nipocalimab (USAN); Nipocalimab (genetical recombination) (JAN); Nipocalimab-aahu; Imaavy (TN) |
(P) unclassified |
| D11674 |
Berotralstat hydrochloride (JAN/USAN); Orladeyo (TN) |
(P) CYP inhibition: CYP3A4 |
| D11696 |
Crovalimab (USAN/INN); Crovalimab (genetical recombination) (JAN); Crovalimab-akkz; Piasky (TN) |
(P) unclassified |
| D11703 |
Opinercept (INN) |
(P) unclassified |
| D11708 |
Givosiran sodium (JAN); Givlaari (TN) |
(P) unclassified |
| D11713 |
Selpercatinib (JAN/USAN/INN); Retevmo (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D11725 |
Futibatinib (JAN/USAN/INN); Lytgobi (TN) |
(P) unclassified |
| D11757 |
Inebilizumab (USAN/INN); Inebilizumab (genetical recombination) (JAN); Inebilizumab-cdon; Uplizna (TN) |
(P) unclassified |
| D11784 |
Vonoprazan (USAN/INN) |
(P) Enzyme: CYP2C19 CYP3A4 / CYP inhibition: CYP3A4 CYP2D6 CYP2C19 |
| D11785 |
Oteseconazole (USAN/INN); Vivijoa (TN) |
(P) unclassified |
| D11793 |
Zuranolone (JAN/USAN/INN); Zurzuvae (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D11804 |
Aspirin and vonoprazan; Cabpirin (TN) |
(P) unclassified |
| D11814 |
Tisotumab vedotin (USAN/INN); Tisotumab vedotin (genetical recombination) (JAN); Tisotumab vedotin-tftv; Tivdak (TN) |
(P) unclassified |
| D11815 |
Belumosudil (USAN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D11816 |
Belumosudil mesylate (USAN); Belumosudil mesilate (JAN); Rezurock (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D11817 |
Deucravacitinib (JAN/USAN); Sotyktu (TN) |
(P) Enzyme: CYP1A2 / CYP inhibition: CYP1A2 CYP2D6 |
| D11835 |
Vorasidenib citrate (USAN); Vorasidenib citric acid hydrate (JAN); Voranigo (TN) |
(P) Enzyme: CYP1A2 CYP2C19 / CYP inhibition: CYP1A2 CYP2D6 CYP2C19 CYP2C9 |
| D11838 |
Vilobelimab (USAN); Gohibic (TN) |
(P) unclassified |
| D11843 |
Cendakimab (USAN/INN); Cendakimab (genetical recombination) (JAN) |
(P) unclassified |
| D11861 |
Indacaterol acetate, glycopyrronium bromide and mometasone furoate; Enerzair (TN) |
(P) unclassified |
| D11862 |
Indacaterol and mometasone furoate; Atectura (TN) |
(P) unclassified |
| D11866 |
Deuruxolitinib (USAN) |
(P) Enzyme: CYP1A2 / CYP inhibition: CYP1A2 CYP2C9 |
| D11867 |
Deuruxolitinib phosphate (USAN); Leqselvi (TN) |
(P) Enzyme: CYP1A2 / CYP inhibition: CYP1A2 CYP2C9 |
| D11876 |
Efgartigimod alfa (USAN/INN); Efgartigimod alfa (genetical recombination) (JAN); Efgartigimod alfa-fcab; Vyvgart (TN) |
(P) unclassified |
| D11881 |
Amlodipine benzoate; Katerzia (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D11887 |
Daridorexant hydrochloride (JAN/USAN); Quviviq (TN) |
(P) unclassified |
| D11920 |
Pimitespib (JAN); Jeselhy (TN) |
(P) unclassified |
| D11952 |
Axatilimab (USAN/INN); Axatilimab (genetical recombination) (JAN); Axatilimab-csfr; Niktimvo (TN) |
(P) unclassified |
| D11954 |
Belzutifan (JAN/USAN/INN); Welireg (TN) |
(P) Enzyme: CYP2C19 / CYP inhibition: CYP2C19 |
| D11970 |
Ritlecitinib tosylate (USAN); Ritlecitinib tosilate (JAN); Litfulo (TN) |
(P) CYP inhibition: CYP1A2 |
| D12015 |
St. John's wort; SJW |
(P) unclassified |
| D12050 |
Pirtobrutinib (JAN/USAN); Jaypirca (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 CYP2C19 |
| D12055 |
Sotorasib (JAN/USAN); Lumakras (TN) |
(P) unclassified |
| D12066 |
Spesolimab (USAN/INN); Spesolimab (genetical recombination) (JAN); Spesolimab-sbzo; Spevigo (TN) |
(P) unclassified |
| D12182 |
Rozanolixizumab (USAN/INN); Rozanolixizumab (genetical recombination) (JAN); rozanolixizumab-noli; Rystiggo (TN) |
(P) unclassified |
| D12213 |
Tolebrutinib (JAN/USAN/INN) |
(P) unclassified |
| D12217 |
Imlunestrant tosylate (USAN); Imlunestrant tosilate (JAN); Inluriyo (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D12245 |
Lazertinib mesylate (USAN); Lazertinib mesilate hydrate (JAN); Lazcluze (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D12246 |
Tegoprazan (INN) |
(P) unclassified |
| D12251 |
Iptacopan (USAN/INN) |
(P) CYP induction: CYP3A4 |
| D12252 |
Iptacopan hydrochloride (USAN); Iptacopan hydrochloride hydrate (JAN); Iptacopan hydrochloride monohydrate; Fabhalta (TN) |
(P) CYP induction: CYP3A4 |
| D12265 |
Mavacamten (JAN/USAN/INN); Camzyos (TN) |
(P) Enzyme: CYP2C19 / CYP inhibition: CYP2C19 CYP2C9 |
| D12285 |
Remibrutinib (JAN/USAN/INN); Rhapsido (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D12311 |
Bortezomib hydrate (JAN) |
(P) unclassified |
| D12326 |
Opelconazole (USAN/INN) |
(P) unclassified |
| D12356 |
Zilucoplan sodium (JAN); Zilbrysq (TN) |
(P) unclassified |
| D12357 |
Zilucoplan (USAN/INN) |
(P) unclassified |
| D12364 |
Taletrectinib adipate (JAN/USAN); Ibtrozi (TN) |
(P) CYP inhibition: CYP2C9 |
| D12374 |
Sibeprenlimab (USAN/INN); Sibeprenlimab (genetical recombination) (JAN); Sibeprenlimab-szsi; Voyxact (TN) |
(P) unclassified |
| D12396 |
Sebetralstat (JAN/USAN/INN); Ekterly (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D12403 |
Venlafaxine besylate monohydrate; Venlafaxine besylate (TN) |
(P) CYP inhibition: CYP2D6 |
| D12410 |
Landiolol (USAN/INN) |
(P) unclassified |
| D12442 |
Tucatinib ethanolate (JAN); Tucatinib hemiethanolate; Tukysa (TN) |
(P) unclassified |
| D12444 |
Nilotinib hydrochloride dihydrate (JAN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D12487 |
Olokizumab (INN) |
(P) unclassified |
| D12493 |
Dextromethorphan hydrobromide and bupropion hydrochloride; Auvelity (TN) |
(P) CYP inhibition: CYP2D6 |
| D12544 |
Vortioxetine hemihydrobromide (USAN) |
(P) Enzyme: CYP2C19 / CYP inhibition: CYP2D6 CYP2C19 CYP2C9 |
| D12586 |
Mifepristone and misoprostol; Mefeego (TN) |
(P) unclassified |
| D12595 |
Aspirin trelamine (USAN) |
(P) unclassified |
| D12596 |
Aspirin trelamine hydrochloride (USAN) |
(P) unclassified |
| D12597 |
Ibuprofen trelamine (USAN); Ibuprofen diethylaminoethyl ester |
(P) CYP inhibition: CYP2C9 |
| D12598 |
Ibuprofen trelamine hydrochloride (USAN) |
(P) CYP inhibition: CYP2C9 |
| D12611 |
Vornorexant hydrate (JAN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D12637 |
Darunavir hydrate |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D12684 |
Efgartigimod alfa and hyaluronidase; Efgartigimod alfa (genetical recombination) and vorhyaluronidase alfa (genetical recombination); Efgartigimod alfa and hyaluronidase-qvfc; Vyvgard hytrulo (TN); Vyvdura (TN) |
(P) unclassified |
| D12704 |
Acalabrutinib maleate hydrate (JAN); Acalabrutinib maleate monohydrate; Calquence (TN) |
(P) unclassified |
| D12747 |
Divozilimab (INN) |
(P) unclassified |
| D12748 |
Levilimab (INN) |
(P) unclassified |
| D12752 |
Darunavir propylene glycolate |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D12816 |
Dexlansoprazole sesquihydrate |
(P) Enzyme: CYP2C19 CYP3A4 / CYP inhibition: CYP3A4 CYP2C19 |
| D12837 |
Risovalisib mesilate hydrate (JAN); Risovalisib mesylate dihydrate; Haizexin (TN) |
(P) CYP induction: CYP2C19 |
| D12963 |
Macitentan and tadalafil; Opsynvi (TN); Yuvanci (TN) |
(CI,P) Enzyme: CYP2C19 / CYP inhibition: CYP2C19 CYP2C9 |
| D12975 |
Nerandomilast (JAN/USAN/INN); Jascayd (TN) |
(P) unclassified |
| D13012 |
Fexuprazan (INN); Abeprazan |
(P) unclassified |
| D13013 |
Ilaprazole (INN) |
(P) unclassified |
| D13026 |
Atogepant hydrate (JAN); Aquipta (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D13167 |
Tegomil fumarate (INN); Riulvy (TN) |
(P) unclassified |
| D13197 |
Linaprazan glurate (USAN/INN) |
(P) unclassified |
| D13198 |
Linaprazan glurate hydrochloride (USAN) |
(P) unclassified |
| D13231 |
Dimdazenil (INN) |
(P) unclassified |
| D13240 |
Zastaprazan (INN) |
(P) unclassified |
| D13243 |
Nafithromycin (INN) |
(P) unclassified |
